Towards The Understanding Of Ccnb1Ip1 As A Co-Regulator Of Meiotic Crossing-Over In The Mouse by Strong, Edward
  
TOWARDS THE UNDERSTANDING OF CCNB1IP1 AS A CO-REGULATOR OF 
MEIOTIC CROSSING-OVER IN THE MOUSE 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
by 
Edward Remco Strong 
January 2014
  
 
 
 
 
 
 
 
 
 
 
 
© 2014 Edward Remco Strong
 TOWARDS THE UNDERSTANDING OF CCNB1IP1 AS A CO-REGULATOR OF 
MEIOTIC CROSSING-OVER IN THE MOUSE 
 
Edward Remco Strong, Ph. D. 
Cornell University 2014 
 
It is clear that there are many genes required for meiosis in mammals that are 
not present in the more tractable model organisms. To identify such genes, our lab has 
performed forward genetic chemical (ENU) mutagenesis screens for alleles conferring 
infertility in mice. A novel allele, Ccnb1ip1mei4, generated in these screens is of interest 
because it is defective in a form of recombination called crossing-over. Ccnb1ip1mei4/mei4 
results in male and female infertility of otherwise normal-appearing animals.  
CCNB1IP1 is finely regulated in both timing and localization to the events of 
meiotic crossover formations. Towards understanding the molecular functions of 
CCNB1IP1 and how the defect in Ccnb1ip1me4i/mei4 animals leads to meiotic arrest, 
studies of CCNB1IP1 within meiocytes implicate a role for CCNB1IP1 in 
SUMOylation. Remarkably little is understood about SUMO-modification 
consequences to meiosis. Protein-protein interactions with CCNB1IP1 identify a 
number of putative targets of SUMOylation, and subsequent in vivo biochemical 
interrogations reveal the CCNB1IP1-interacting proteins 4930455F23RIK and GGN as 
targets of posttranslational modification dependent upon a putative SUMO E3 ligase. In 
totality, these studies support the hypothesis that CCNB1IP1 performs as a meiotic co-
regulator, mediating the SUMO-modification of proteins essential to the stabilization 
and maturation of crossover intermediates. These studies of CCNB1IP1 point towards 
a better understanding of meiosis, with emphasis upon new targets and roles of 
SUMOylation.
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CHAPTER 1 
 
Introduction 
 
 The process of germ cell development was first proposed by August Weismann 
in 1887. In the 126 years since the initial descriptions of reductional and equational 
cell divisions, significant progress has been made in understanding the processes 
underlying those specialized divisions leading to haploid germ cells. Despite our 
understanding of the major initiation and DNA repair events of meiosis that are 
essential to germ cell development, the finer detail regulations of these processes 
remain largely unknown. Furthermore, while meiosis is highly conserved throughout 
eukaryotes, technical difficulties and time to mammalian sexual maturity have 
historically hindered the identifications of more complex regulations of meiosis 
related to our multicellular and sexually dimorphic nature. While the selection of 
genes for targeted mutagenesis in the mouse is often based upon information from the 
more tractable model organisms, it has become clear that there are many genes 
required for meiosis in mammals that are not present in the other models. To identify 
such genes, our lab has performed forward genetic chemical (ENU) mutagenesis 
screens for infertility genes in mice.  
A novel allele, Ccnb1ip1mei4, generated in these screens is of particular interest 
because it is defective in a form of recombination called crossing-over. 
Ccnb1ip1mei4/mei4 results in male and female infertility of otherwise normal-appearing 
animals. Male azoospermia occurs upon meiocyte arrest and apoptosis at metaphase I, 
with complete homologous chromosome desynapsis. Studies into the function of 
CCNB1IP1 within meiocytes implicate a role for CCNB1IP1 in SUMOylation. 
Remarkably little is understood about SUMO-modification consequences to meiosis. 
CCNB1IP1 performs as a meiotic co-regulator mediating the SUMO-modification of 
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 proteins essential to the stabilization and maturation of crossover intermediates. These 
studies of CCNB1IP1 point towards a better understanding of meiosis, with emphasis 
upon new targets and roles of SUMOylation. 
 
1. Meiosis: a specialized and highly conserved cell division 
Meiosis is the defining event of sexual reproduction. The meiotic process of 
producing haploid cells towards reproduction is most generically defined as “one 
round of DNA replication, followed by two rounds of cell division”. While this 
statement is accurate, it grossly oversimplifies a fundamental process of sexual 
reproduction that is both similar to and at the same time highly specialized from 
somatic cell division. The meiotic machinery is conserved in eukaryotes and much has 
been learned from the study of simpler eukaryotes such as Saccharomyces cerevisiae. 
This especially high level of conservation between meiosis of distant species is 
believed to be attributed to a single evolutionary event, likely evolved from mitosis. 
Indeed, much of what is understand about meiosis owes itself to these two principles: 
mitotic DNA repair is the evolutionary father of meiotic DNA repair, and meiotic 
events in simpler species are likely conserved and inform discovery of more complex 
processes in high order species. 
 
Mitotic and Meiotic DNA repair 
While the fate of mitotic and meiotic cells are completely distinct, both 
experience DNA lesions and must repair these genomic insults prior to cellular 
division. Possibly owing to the invading homolog’s sequence polymorphisms, and 
thus nucleotide mispairing in meiotic recombination intermediates, meiotic Double 
Strand Break (DSB) repair owes at least part of its origins to mitotic DNA Mismatch 
Repair (MMR). In recombination-mediated MMR, MutS proteins form a dimer that 
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 bind single nucleotide mispairs and the MutL protein dimer is then recruited through 
interaction with the MutS-DNA complex to coordinate repair [1]. These MMR 
proteins (MutS and MutL homologs) play essential roles in mitotic recombination-
mediated DNA repair [2,3]. In mammals, defects in MMR lead to mutations and 
oncogenesis [4]. While mitotic cells will preferentially repair post-replication genetic 
lesions off the sister chromatid, in meiotic cells repair off the sister is less efficient and 
thus promotes crossing-over between the homologous chromosomes and the resulting 
recombination-driven synapsis. In meiotic, as in mitotic cells, this crossing-over is at 
least partially dependent upon the RecA homolog Rad51 to promote single-stranded 
DNA (ssDNA) invasion of the template [5]. 
While the purpose for, and the ordering of, events in mitotic and meiotic 
recombination may differ, their intermediates share informative similarity. Mitotic 
MMR recognizes DNA replication errors to initiate DNA damage repair correcting the 
error, whereas meiotic cells initiate DNA damage to force interhomolog 
recombination-dependent repair of the lesions. From these mitotic origins, much has 
been inferred and subsequently validated towards the understanding of meiotic 
recombination intermediates, chromatin remodeling, and regulation of protein 
functions. 
 
Meiosis Overview 
In the phase of meiosis, cells undergo DNA replication followed by an 
elaborate prophase (meiotic prophase I) in which the chromosomes align, recombine, 
and divide in a manner that halves the number of homologs but retains the sister 
chromatids (the “reductional division”). Prophase I is cytologically classified into 
stages based upon chromosome behavior and appearance of a proteinaceous structure 
known as the Synaptonemal Complex (SC) which tethers together aligned 
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 chromosomes. In the first stage of prophase I, leptonema, a protein scaffold known as 
the Axial Element (AE) forms between the sisters chromatids that functions to bind 
the chromatids together until the second meiotic division (the equational division of 
meiosis II). Once the AE are fully formed along the length of sister chromatids, 
meiocytes enter zygonema in which the AEs of homologous chromosomes align and 
begin to physically tether together through a third protein scaffold (the first two 
scaffolds are the AEs belonging to opposing homologs) known as the Central Element 
(CE). As the CE begins to “zipper” the homologs together, the AEs become known as 
lateral elements (LEs) of the tripartite SC. Complete formation of the SC core along 
chromosome axis, full synapsis, is the defining feature of pachynema. During 
pachynema chromosomes will mature the intermediate physical exchanges of DNA 
which, as crossovers, will tether homologs together as the SC begins to disassemble at 
entry into diplonema. The physical tethering of DNA, manifested as chiasmata, 
represent sites of meiotic homologous recombination that both ensures genetic 
diversity and maintains homolog association for reductional division of Meiosis I 
(MI). Chromosomes that fail to undergo crossing-over are at great risk of 
missegregation as the cells enter the first meiotic division, resulting in aneuploidy. 
Aneuploidy of a developing embryo/fetus is causal of early lethality or developmental 
defects and, as such, meiocytes have evolved “checkpoint” surveillance mechanisms 
through which to halt meiosis upon errant prophase I. As homologous chromosomes 
separate in the reduction division of MI, cells enter into the cycle of the second 
meiotic division (MII). In MII, the cells bypass DNA replication and enter into the 
equational division in which sister chromatids are separated in a manner analogous to 
mitotic division. 
 The stages, DNA processing, and much of the fundamental genetics of meiosis 
are shared between sexes of sexual dimorphic animals such as mouse and human. 
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 However, the timing and checkpoint mechanisms in mammals can differ. Whereas 
males will initiate meiosis postnatally, followed immediately by spermiogenesis 
(maturation of haploid cells in sperm); their female counterparts will initiate meiosis 
during embryonic development. However, the development of female haploid germ 
cells will arrest and restart on two distinct time points and only complete meiotic 
divisions following fertilization by the sperm. 
In sexually reproducing animals, the end product of meiosis are the gametes 
which function to contribute genetic material into the offspring. The classical “one 
round of DNA replication followed by two rounds of cell division” is more accurately 
described as two sequential, but fundamentally differing, specialized cell divisions: 
Meiosis I and Meiosis II. Following DNA replication, the homologous chromosomes 
separate in MI. This MI division nets two haploid cells (secondary spermatocytes in 
the male; oocyte and 1st polar body in the female). In MII, DNA replication is 
bypassed and the second meiotic division separates the sister chromatids that co-
segregated in MI. Many of the fundamental meiotic process have been characterized in 
fungi and other genetically tractable organisms but much remains to be understood 
about the fine-detail molecular actions in each step. 
In mammals, although the principal processes and proteins of this meiotic 
progression remain conserved between the sexes, there are notable differences. First 
among this sexual dimorphism is the timing of meiotic program initiation [6]. During 
fetal development, the female will initiate meiosis in the primitive gonad, and during 
embryogenesis the oocytes will progress through prophase of MI but arrest during 
diplotene, prior to the first meiotic division. This arrest in the female, dictyate arrest, 
will hold the oocytes developmentally stationary until resumption of meiosis is 
triggered in the sexually mature adult ovary. Upon release from arrest, oocytes will 
complete the first meiotic division, releasing the first polar body and the developing 
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 oocyte completes diakinesis. The oocyte will arrest again, awaiting fertilization to 
trigger completion of MII with extrusion of the second polar body and forming a true 
gamete to receive the haploid genome supplied by the fertilizing spermatid. Although 
meiosis in the male will be delayed from the initiation in the female, beginning 
postnatally, males are not subject to the arrests seen in females. 
 
2. Discovery of relevant genes 
 Likely due to a single evolutionary event, the meiotic machinery is highly 
conserved in eukaryotes and much has been learned from the study of simpler 
eukaryotes such as Saccharomyces cerevisiae. Many of the major events of meiosis 
identified in lower eukaryotes (yeast, plants, flies, and worms) have been later 
confirmed or shown consistent with events in higher order animals. However, the 
molecular events principal to meiosis have evolved additional complexities particular 
to the sexual reproduction in organisms such as mammals. While we have a 
fundamental understanding of mammalian reproduction, it is through forward genetics 
that we can gain knowledge and understanding of these unknown levels of complexity 
and order relevant to our own species. 
 Genomic and proteomic analysis have offered new tools toward the unbiased 
discovery of essential genes/proteins in meiosis. Forward genetics was once the tool of 
discovery, but “-omics” has in many ways taken over this role. While genomic and 
proteomic studies can offer candidates to cytologically verify location and expression 
patters as consistent with meiotic functions, their ability to validate function is 
fundamentally limited. Ultimately, reverse genetics and rigorous biochemistry is 
necessary to validate functions. 
 To the benefit of those interested in the genomic profile of meiocytes, the 
coordinated first wave of spermatogenesis has been well characterized in the male 
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 mouse: 10-11dpp, leptonema; 12-13 zygonema; 15-16dpp, pachynema; 17-18dpp, 
diplonema [7,8]. Using samples enriched for these cellular populations, studies have 
profiled the RNA transcripts and built expression patterns that have been mined for 
candidate genes for further study [9,10]. 
 The technological innovations in proteomics have led to increased sensitivity 
and accuracy. These advancements, as well as convergence with more traditional 
techniques such as gel separation and co-immunoprecipitation (co-IP), are driving 
interest in new proteomic screens built from principles utilized in genomic screens. 
Increased resolution in proteomic profiling will present the opportunity to finely 
identify posttranslational modifications of the proteome. Posttranslational 
modifications of acetylation, methylation, and phosphorylation have been extensively 
studied for their effects on mitotic chromatin structure and DNA repair. However, 
through new sensitive proteomic tools, we can assess the wider array of 
posttranslational modification as well as their roles in meiosis whereas previously 
limited materials reached the detection thresholds of proteomic assays. 
 
3. The events of prophase I 
Prophase I of meiosis has been said to be “where all the action takes place”. To 
accommodate “all the action”, prophase I accounts for over 90% of the total meiotic 
duration [11]. It is in Prophase I that homologs synapse, recombine, and resolve 
though progression into the reductional division. Fidelity of prophase I is critical to 
assure genetic diversity and avoid aneuploidy resultant from homolog mis-
segregation. Whereas MII is the somatic-like equational cell division (albeit lacking in 
the DNA replication cycle), MI has attracted the most study with particular interest on 
the intricate steps of prophase I. 
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 Initiation and homolog synapse: 
Programmed Double Strand Breaks are the initiating event of meiotic 
recombination. Meiotic cells initiate autonomous DNA damage and it is the repair of 
this damage that consequently drives what we define as the events of meiotic 
recombination. This DNA damage is preferentially repaired through use of the 
homologous chromosome template and thus homologs must pair at the many sites of 
DNA damage. Indeed, observations in many organisms confirm that homologs 
associate at many nucleating sites from which longer stretches of physical attachment 
polymerize. This alignment of chromosomes coincides with Rapid meiotic Prophase 
chromosome Movements (RPMs) in fungi and in mammals [12,13]. These 
chromosome movements are hypothesized to search the nucleus and facilitate 
homolog associations. While it remains formally unverified, current hypotheses 
suggest RPMs function as a physical test of the DSB repair mediated homology 
search; non-homologous associations will disperse with mechanical RPM force while 
true homology will endure [14,15]. 
 
Initiation: 
RA stimulation of meiosis is followed by the initiating meiotic event of cell-
autonomous programed DNA damage. Meiosis has been purposefully evolved to 
provide for haploid gamete production and genetic mixture. The programmed DNA 
damage, by way of DSBs, is a genomic insult catalyzed by the topoisomerase Spo11 
[16]. Homologs of Spo11 can be found in all eukaryotic models of meiosis, owing to 
the inciting role of this enzyme and the conservation in primary meiotic machinery. In 
the mouse, as in yeast, homolog alignment is driven through search for a homologous 
repair template, necessary because of the DSB insults generated by SPO11. In yeast, 
where Spo11 has been best characterized, there are no less than 9 accessory proteins 
8 
 
 (Mre11, Rad50, Xrs2, Mei4, Rec102, Rec104, Mer2, Ski8, and Rec114) [17] that are 
essential for Spo11 catalyzed DSBs. Following the initiating events of DSB insults, 
repair processes are signaled through which a complex synchronization of 
transcription, translation, and post-translational modifications function to repair the 
DNA while simultaneously providing the mechanisms through which homologs will 
properly segregate in anaphase.  
In order to repair these genomic insults, the SPO11 catalyzed DSBs are 
resected to leave a 3’ overhang to provide for search of a repair template and will thus 
facilitate homologous chromosome associations. Defects in DSB formation or 
processing lead to inefficient and precocious homolog pairing, followed by arrest or 
aneuploidy at the first meiotic division [16]. The invasion of the homolog by the 3’ 
ssDNA overhang forms what is called the D-loop. The system of homology search is 
surely more complex than the conceptual ssDNA homology search pushed towards the 
homologous chromosome, and is still largely unknown.  In mice, as in yeast, the 
homologs of ancient DNA repair protein RecA (RAD51 and DMC1) associate with 
the ssDNA [19,5]. DMC1 and RAD51 facilitate ssDNA invasion and D-loop 
formation [20]. The SC protein SYCE1 is known to physically interact with RAD51 
and it may be through this interaction that RAD51 association with ssDNA initiates 
homologous synapse [21]. As a diagnostic tool, RAD51 localization in the mouse can 
be identified at about 250 chromatid loci per meiocyte and can serve as proxy to 
identify the number of DSBs and thus D-loop formations. Many other proteins play a 
role in meiotic DNA repair, including the co-regulators ATM and ATR kinases which 
impart altered functions upon the diverse proteins they phosphorylate. Recently, it has 
been shown that ATM is activated in response to SPO11 catalyzed DSBs, and ATM 
kinase will initiate a cascade that will negatively feedback upon SPO11 to regulate 
DSB formation. Mutants defective for ATM show a severe increase in DSB formation 
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 due to a lack of negative feedback regulation [22]. ATR kinase has been shown to 
localize at unsynapsed regions of chromosomes and plays an important role in 
regulating epigenetic marks which repress gene expression from unsynapsed meiotic 
chromosomes [23]. 
The mechanisms directing selection of those sites to receive DSBs remain 
incompletely characterized. Nevertheless, it is clear that some hotspot locations in the 
genome are more susceptible to DSBs. In the mouse, the most well characterized 
determinant of hotspot location is the trans-acting regulator, H3K4 methyltransferase 
PRDM9 [24]. PRDM9 is given DNA-binding specificity though an array of 12 zinc 
fingers [25]. Hotspot sites for DSBs have been correlated with H3K4 trimethylation 
(H3K4me3) [26]. Genomic studies to map hotspot locations have found that genomic 
loci with the PRDM9 predicted binding motif are 180 times more likely to receive a 
DSB [27]. 
 
Testing true homology: 
 RPMs are hypothesized to act as mechanical tests against precocious 
homologous pairing, and/or disentangle chromatid fibers as cells prepare for 
homologous synapse. In the mouse, dynamic movements of telomeres coalesce into a 
singular nuclear envelope domain, telomere bouquet, during the leptotene/zygotene 
transition. The bouquet formation in mammals is facilitated by SUN1, SUN2 and the 
meiosis-specific KASH5 which localize to the telomeres at leptotene and tether the 
chromatids to the cytoplasmic microtubules providing the mechanical force for RPMs. 
Mice deficient for the nuclear envelope associated SUN1 lose telomere-envelope 
attachment, thus RPMs, and are defective for chromosome synapse [28]. Additionally, 
loss of the cohesin protein SMC1β also results in failed telomere-envelope attachment 
[29], illustrating the dependence of sister-chromatid cohesin complex upon RPMs and 
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 further strengthening the observed relationships between cohesin complex, 
synaptonemal complex formation, and homologous alignment. 
 
Stabilization of intermediates: 
 Repair mediated by D-loop formation can proceed through non-crossover and 
crossover pathways, synthesis dependent strand annealing (SDSA) and reciprocal 
DNA exchange, respectively. The reciprocal DNA exchange of crossing-over forms 
the classical double Holliday Junction (dHJ). The joint molecule of the dHJ is resolved 
as either Class I (interference dependent recombination), or Class II (gene conversion) 
events. The decision for DNA repair resolution is believed to be made very early, with 
the majority of lesions repaired through SDSA and the bulk of the remaining DSBs 
repaired as Class I events [30]. In the yeast, this early repair pathway decision is 
mediated by the Dmc1 protein. The Rad51 protein is dispensable for the specification 
of crossovers, however crossing-over is lost in the absence of the Dmc1 protein [31]. 
Interestingly, the role of RAD51 may not be limited to its interaction with SYCE1 in 
promoting D-loop formation; yeast two-hybrid experiments have found that RAD51 
interacts with the SUMO-conjugating enzyme UBC9, suggesting a role for RAD51 in 
recruiting posttranslational co-regulation at the sites of DNA repair [32]. Indeed, from 
yeast we understand that the AE protein Red1 binds Smt3/SUMO-conjugates [33] 
possibly facilitating Red1 coordination of meiotic recombination and synapsis. It is 
suggested in yeast that Smt3/SUMO-conjugated Zip3 (an essential SC protein) 
complexes with Red1, and that Red1 promotes phosphorylation of Hop1 which in turn 
promotes inter-homolog recombination. These observations build a Smt3/SUMO-
dependent coordination between SC elongation and meiotic recombination [33,34]. 
 
Synaptonemal Complex Formation 
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 The SC is a dense scaffolding of protein-protein interactions that physically 
tether homologous chromosomes together during meiosis. Since the SC’s initial 
description in 1956 [35,36], much research has been focused on this central structure. 
Unfortunately, while we have discerned the major cytological events and identified a 
number of constituent proteins, it is clear that the SC is incompletely characterized and 
much is still being learned about its assembly and disassembly. 
 In preparation for SC formation, the chromatin itself reorganizes as a 
coordinated event receptive to the initiating events of recombination. Notably, 
epigenetic status of histones is a common mechanism of somatic cells to govern 
chromatin remodeling and the principle holds true in meiotic cells. Changes in 
epigenetic modifications to histones promote chromatin compaction that facilitates 
homolog pairing and installation of the SC. Ubiquitination of histone 2B (H2b) protein 
by Rad6 and methylation of Histone 3 (H3) by Set1 together promote nucleosome 
architecture that remodels the yeast meiotic chromatin [37,38]. Indeed, the well-
known histone variant H2AX which mediates DSB detection and recruitment of DNA 
damage response factors has recently been shown to be posttranslational modified by 
ubiquitin, and SUMO [39].  
 Leptonema follows shortly after the recombination initiating events of SPO11 
catalyzed DSBs. As the homologs remodel, condense, and begin to congress, 
proteinaceous AEs begin to form in short stretches along the chromosome core. The 
best understood building blocks of the AE are heterodimeric partners SYCP2 and 
SYCP3. It has been postulated that these short AE segments originate at D-loop 
locations and RAD51 facilitates the seeding of this AE formation [40]. SYCP2 
contains a coiled-coil domain that is essential for its interaction with SYCP3 [41]. 
Mice defective for either SYCP2 or SYCP3 fail to form AEs, and thus fail to assemble 
the SC. Likewise, these meiocytes experience significant aneuploidy from homolog 
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 disassociations. Later research implicates the coiled-coil protein SYCP2 as the master-
link building the AE and assembling the AE into the final SC structure [42]. 
 As the cells enter into zygonema, the AEs have formed along the lengths of 
homologs and the third piece of the tripartite SC, the Central Element, begins to 
“zipper” the homologs together. The CE assembly is dependent upon Transverse 
Filament (TF) protein SYCP1. The TF constituent SYCP1 is itself also a coiled-coil 
domain containing protein and builds the CE through its own homo-dimerization; the 
C-terminus of SYCP1 associates with the LE to create the TF, and the N-terminus of 
each homolog TF associates with the other to physically join the LEs and build what is 
together known as the CE [43]. The physical association between LE and TF is 
through SYCP2 which interacts with the C-terminus of SYCP1 [42]. As zygonema 
progresses, the SC forms longer stretches and the homologs near full alignment. 
 As the homologs fully synapse and CE forms along the full length of the 
chromosome cores, the meiocytes enter pachynema. In pachynema the autosomes 
have fully assembled the SC, and the XY have synapsed along the pseudoautosomal 
region. Due to the high level of asynapsis along the larger X chromosome, the XY is 
sequestered into a distinct Sex Body domain and transcriptionally silenced in a process 
called Meiotic Sex Chromosome Inactivation (MSCI). The sex body is commonly 
defined as a readily observed phosphorylated-H2AX (ɣH2AX) enriched domain. More 
recent fine cytology has observed that SUMO-conjugates proceed ɣH2AX localization 
at the sex body domain [44]. Presumably the sex body is sequestered to protect it from 
the autosomal asynapsis surveillance mechanisms of prophase I, but the coincidence 
of SUMO and ɣH2AX at the sex body as well as DNA lesions and asynapsis remains 
poorly understood [45]. Asynapsed autosomes, from either errors in SC assembly or 
highly divergent genetic backgrounds, trigger transcriptional silencing similar to 
MSCI called Meiotic Silencing of Unpaired DNA (MSUD). Together MSCI and 
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 MSUD fall under a general principle called Meiotic Silencing of Unsynapsed 
Chromatin (MSUC) [46].  
 While we know the identities and biochemistry behind SC-forming SYCP1, 
SYCP2, and SYCP3 we know that many other proteins are either intrinsic building 
blocks of the SC or localize with the SC to coordinate DSB repair. Genomic profiling 
identified candidate genes Syce1, Syce2, and Syce3 (Synaptonemal Complex Central 
Element Protein 1/2/3) as essential to meiosis. Studies of these proteins hypothesized 
their localization to the SC in part due to their large coiled-coil domains. Indeed, this 
family localizes to the SC and mice mutated for each member display synapsis defects 
[47-49]. Furthermore, in yeast a Smt3/SUMO mutant carrying an allele in which all 
nine lysine residues in the Smt3 protein are mutated, and thus unable to form 
polymeric Smt3 chains, are defective in longer stretches of SC assembly [50]. In the 
Smt3-allR yeast cells, SUMOylation is at least partially functional and SUMO-
conjugates can receive Smt3 monomers sufficient to recover the cell lethality seen in 
smt3 null cells. The Smt3-allR results suggest that polymeric Smt3/SUMO chains 
prior to synapse are needed for extensive SC formation. The inability of Smt3-allR 
mutants to propagate SC formation into longer stretches is similar to the short SCs 
observed in zip3 null yeast cells. Yeast mutated for the AE protein and SUMO E3 
ligase Zip3 fail to properly extend SCs to full synapse, further suggesting essential 
function of Smt3/SUMO-modified AE proteins in SC polymerization [51,52]. 
Although loss of Zip3 results in loss of AE SUMOylation in pachynema, extensive 
Smt3-conjugates remain in early prophase indicating that the Smt3/SUMO circuitry is 
more robust than a single E3 ligase. Additionally, these studies with Smt3 found that 
when SC formation was otherwise disrupted, independent of Zip3 protein, Smt3 co-
localized with the precocious Zip1 polycomplexes [50]. Taken together, these 
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 interrogations of SC constituents reveal a level of SC complexity previously 
underappreciated despite its long history as a focus of research. 
 
Repair of Meiotic Double Strand Breaks 
Recombination-mediated repair of DBS proceeds through formation of 
homologous DNA exchange, otherwise known as crossing-over. While this crossing 
over is beneficial towards promoting genetic diversity, within the context of meiosis 
the recombination is secondary to the essential function of maintaining homologous 
chromosome alignment through physical attachment of the joint molecules in crossing 
over. 
 Recombination intermediates can be resolved through the interference-
sensitive Class I pathway of homologous recombination that forms physical crossing 
over, or alternatively though the interference-independent Class II gene conversion. 
Class I recombination is subject to interference promotion of crossing over 
distribution, thus ensuring distribution and the singular obligate crossover required per 
homolog pair, a process together known as crossover homeostasis that ensures the 
frequency of crossing-over remains controlled [53]. 
 As has been discussed, there is apparent coordination between the SC forming 
factors (SYCP1, SYCP2, and SYCP3), the SC associated factors (SYCE1, SYCE2, 
SYCE3, ZIP3, Smt3/SUMO), and the early recombination intermediates (RAD51, 
DMC1, D-loop formation). Whereas the majority of RAD51 marked DSBs will be 
repaired though non-crossover SDSA, some subset will be specified towards those 
essential sites of crossing-over. Those sites of crossing-over manifest as protein dense 
nodules, Meiotic Nodules (MNs), which are testament to the complex protein-protein 
interactions stabilizing and resolving DNA exchange [54, 55]. Early MNs will be 
largely resolved as gene conversions rather than reciprocal crossing-over [56, 57]. It 
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 remains an area of great interest to identify the co-regulators and enzymes involved in 
this crossover fate determination.  
 While early MNs demarcate initial recombination events, late MNs are 
considered more protein dense and are believed to represent sites of physical DNA 
crossing-over called chiasmata [58]. The relatively numerous early MNs mature down 
to a few in number late MNs by late pachynema. As the SC dissembles in diplonema, 
these remaining chiasmata will be resolved as reciprocal crossovers [56,57]. 
 In the selection from the hundreds of early MNs and to the final 20-25 late 
MNs in the mouse, the mismatch repair proteins (MMR) MSH4 and MSH5 are known 
to function in stabilization of sites destined as crossovers. MSH4 and MSH5 are 
meiosis-specific MMR proteins which, as a family, are homologs of the ancient 
bacterial MutS DNA repair proteins. Through hydrolysis of ATP, the MSH4-MSH5 
heterodimer recruits further MSH4-MSH5 complexes to form a sliding clamp and 
stabilize the dHJ of recombination-mediated DNA repair [59,60]. As MNs mature, 
intermediate MNs are marked by the MSH4-MSH5 heterodimer and immunolocalized 
foci decrease in numbers from approximately 150 in zygonema, to about 30 foci in 
pachynema as recombination intermediates mature towards the 20-25 reciprocal 
crossover events. In the mouse, one current hypothesis for co-regulator selection of 
intermediate MNs as sites of future crossing-over involves SUMOylation of unknown 
conjugates. It is postulated that putative SUMO E3 ligase RNF212/Zip3 stabilizes 
those MSH4-MSH5 heterodimers destined towards crossing-over [61]. 
 From studies in the yeast, we know that the meiosis-specific MutS homologs 
recruit the eukaryotic MutL homologs, MLH1 and MLH3, to the sites of late MNs 
[62]. In pachynema, MLH1 and MLH3 localizations mark the sites of crossing-over 
[63,64]. In the mouse, potential resolvase factors have been localized to these terminal 
sites of crossing-over but it is still unknown which factors mediate resolution of the 
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 dHJ into reciprocal crossing-over. It remains a factor of great interest to better 
understand these resolving events in meiotic recombination: final stabilization of sites 
for Class I crossing-over, and resolution of the dHJ joint molecules. 
 
Removal of the Synaptonemal Complex 
 With crossovers specified and homologs physically tethered at the points of 
chiasmata, the SC has served its function to maintain scaffolding while 
recombinogenic events progress. In diplonema, the SC begins to disassemble; TF 
protein SYCP1 is lost and the homologs repel each other. The sites of reciprocal DNA 
exchange are the final strong link associating homologs as they align for completion of 
MI. Animals homozygous for mutations in Mlh1 and Mlh3 fail to maintain sites of 
crossing-over and thus homologs fully repel into univalents during diplonema, leading 
to total infertility (64,65). By diakinesis, crossovers have resolved and the homologs 
remain paired only at the centromeres, align in metaphase, and the first meiotic 
division occurs. 
 
4. Posttranslational modifications in meiosis 
Posttranslational modifications regulate protein activity, localization, stability, 
and protein-protein interactions. In mouse meiocytes, it is interesting to note that the 
bulk of observed posttranslational modifications have functional relationships towards 
transcriptionally repressed heterochromatic regions. Posttranslational modifications in 
the spermatocyte localize/exclude at the domains of MSUC, and pericentromeric 
chromatin. The prominence of posttranslational modifications at regions of MSUC 
may indicate their role in genome defense. Other observations of posttranslational 
modifications have occurred at the sites of DNA damage, suggesting their role in 
signaling DDR. The most well-known meiotic posttranslational modification is the 
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 ATR-dependent phosphorylation of H2AX (ɣH2AX) in response to both DNA 
damage and MSUC. While ɣH2AX is the most well recognized mark of 
heterochromatic domains in spermatocytes, the transcriptionally repressive mark, 
H3K9me2, is found at the sex body and likewise activating marks of acetylation, and 
H3K27-methylation are excluded from the sex body (66,67). While the functions are 
not understood, pericentromeric heterochromatic regions of spermatocytes display 
H3S10p from pachynema followed by H4K5ac and H4K16ac in diplonema [68]. And 
of course, ubiquitin-like modifications have been observed, with ubiquitination of 
H2A localizing to the sex body and involved in MSCI [69], and the previously 
discussed SUMOylation of H2AX [70].  
Modification of proteins by the Small Ubiquitin-like MOdifier (SUMO) 
peptide is a poorly understood influence upon meiotic DNA repair. Where the more 
well-defined modifications of ubiquitination, phosphorylation, and acetylation have 
been identified and studied in somatic and meiotic cells to varying degrees for 
decades, SUMO-conjugates are more recent discoveries. SUMOylation is a covalent 
modification that alters fate or activity of proteins. The growing body of research in 
the last decade has shown SUMO to be influential in many cell types, including those 
of germ cells at all stages. Proteomic studies using available resources and material of 
somatic cells has identified hundreds of targets for SUMO-conjugation [71]. However, 
in the testis, the most experimentally tractable of the gonads, SUMO-conjugates 
remain largely uncharacterized but work has identified SC proteins SYCP1 and 
SYCP2 as SUMOylated in human males [72], and SUMO-conjugates at DSB sites of 
both mitotic and meiotic cells in the mouse [73]. In somatic cells, SUMOylation of 
topoisomerases TOPI and TOPII are seen in response to DNA damage, suggesting a 
larger link between SUMO and topoisomerase catalyzed damage [74]. Cytological 
studies in the mouse testis implicate SUMO involvement in meiotic recombination and 
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 MSCI, with localization to both sites of DSBs and the sex body. Such localizations 
make SUMOylation interesting for its presumed roles in regulation of crossing-over, 
and MSUC. As of yet, few targets of SUMOylation are known, fewer are understood, 
and even less is known about the co-regulators that specify proteins for SUMOylation.  
While the first substrate for SUMO was identified in vertebrates, RanGAP1, it 
has been through yeast that the understanding of SUMO-activating and –conjugating 
enzymes was described [75]. SUMO conjugation is analogous to ubiquitin 
conjugation: the C-terminal carboxyl group of Smt3/SUMO is activated by 
adenylation through the E1-like enzyme. While SUMO is then tightly bound to the E1 
through a thioester bond, activated SUMO is transferred to the only known E2, 
Ubc9/UBE2I; the E2 enzyme can now transfer SUMO to a lysine residue of the 
substrate. Analogous to ubiquitination, the transfer from E2 enzyme to substrate is 
specified through an E3 ligase which functions to bridge the substrate to E2 and 
provide favorable specificity and kinetics. Since SUMO and ubiquitin can compete for 
the same lysine residues, it has been canonically proposed that SUMOylation 
functions to protect from ubiquitin-mediated degradation [76]. Identification of 
SUMO Interacting Motif (SIM) domains broadened the understanding of SUMO to 
offering an additional surface onto substrates through which to build protein-protein 
interactions or alter localizations [77]. 
In yeast, the often studied SC promoting Zip3 protein was identified as an SP-
RING (Siz/PIAS-type RING) containing protein and subsequently verified as a SUMO 
E3 ligase [78]. Those studies further found that zip3 mutants retain Smt3/SUMO-
conjugates that are SC-, recombination-, and cell cycle-dependent, thus implicating 
additional complexity in E3 ligase co-regulation. An additional level of complexity, 
with possible implications to meiotic DSB repair, found that in somatic cells the DSB 
repair protein BRCA1 is recruited to DSBs though hybrid SUMO-Ub chains which are 
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 specified by a new class of SUMO-targeted Ubiquitin E3 ligases (STUbL) [79]. These 
newly appreciated hybrid SUMO-Ub chains and the class of STUbLs have already 
been proposed as a more general signal mediating recruitment of DSB repair factors to 
damage sites (80,81). 
 
5. Check point control of Meiosis I 
Meiosis I defects trigger checkpoints which either delay the cell and 
accommodate repair, or arrest the cell. In sexually dimorphic mammals, defects in 
meiosis I commonly result in infertility due to failure to properly segregate 
homologous chromosomes. In the females of these animals, oogenesis checkpoints are 
not considered to be as stringent as those of spermatogenesis and phenotypes vary 
from infertility due to meiotic arrest and aneuploidy leading to embryonic lethality or 
birth defects [6]. Notably, many such spermatogenesis defects arrest at the entry into 
pachynema with chromosome pairing defects, and thus lack any progress into 
metaphase. Mutations in Spo11, Mei1, Dmc1, Msh4, Msh5 each display pre-pachytene 
arrest, albeit due to varying deficiencies in the initiation or progression of DSB repair 
(18,82-85). This arrest at pachynema is triggered by two surveillance mechanisms: the 
synapsis checkpoint and the recombination checkpoint. In mutants with failure to 
initiate synapse, chromosome cores localize BRCA1 which recruits the ATR kinase 
that phosphorylates H2AX thus leading to MSUC (86,87). This silencing of autosomal 
domains may lead to repression of meiotic genes and thus arrest of development [88]. 
Until recently, studies of the recombination checkpoint in mice were not possible. The 
report of mutation of Trip13 in the mouse has uncovered the separation mutant which 
displays accurate synapsis while still activating the recombination checkpoint [89]. 
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 Future work with Trip13 will lead towards understanding the recombination 
checkpoint in mammals. 
Mutations affecting events post-pachynema are seen to trigger the spindle 
checkpoint, which delays meiosis I at metaphase and prevents segregation of the 
homologous chromosomes. In the mouse, the crossing-over defects observed in alleles 
of Mlh1, Mlh3, and Ccnb1ip1 result in asynapsis at diplonema, thus spindle tension 
defect, and arrest prior to entry into Meiosis II. The spindle checkpoint is highly 
conserved between meiosis I, II, and mitosis.  
 
6. Significance of this work 
Meiosis is a specialized, highly developed, ancient process that enabled sexual 
reproduction towards the spread of genetic diversity, facilitating species robustness. 
Likely owing its derivation to mitotic division and DNA repair, it displays both 
striking mechanistic similarity and fundamental divergence. The apparently singular 
evolution and subsequent high conservation within meiosis across the species has led 
to great insights on the defining events, and their responsible proteins that are shared 
across species. But the additional complexity in species relevant to our own, as well as 
the co-regulators and fine understanding of checkpoints remain much of a mystery in 
the 126 years since the original cytological observations described by August 
Weismann. 
 Prophase I is of particular interest due to the complexity and defining events 
that take place. Beyond current understanding of the proteins involved in 
recombination initiation, stabilization of intermediates, and those proteins which 
ultimately mark the sites of essential reciprocal crossing-over, little is known about the 
co-regulators which aid in the selections of these recombinogenic sites. Furthermore, 
even less is understood about the effects of posttranslational modifications on both the 
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 chromatin structure, and the enzymes which access the chromatin and provide for 
crossover events. It is both this higher order complexity, and meiotic regulation events 
in mammals that these efforts here hope to build insight towards and inform future 
research.  
 In this thesis I will interrogate the biochemistry and cytology of CCNB1IP1. 
The meiotic relevance of CCNB1IP1 was revealed through a forward genetic screen 
for fertility mutants in the mouse [90]. The mei4 allele was mapped to Ccnb1ip1 and 
the resultant CCNB1IP1mei4 is at least partially defective. Ccnb1ip1mei4/mei4 animals fail 
to specify terminal class I crossing-over, display asynapsis, and thus male and female 
infertility [91]. 
 As discussed, from other works we know that specification of crossing-over 
involves localization of at least one SUMO E3 ligase, RNF212/Zip3. Sites of DNA 
repair localize SUMO-conjugates and synapsed cores contain SUMOylated structural 
elements. More broadly, regions of MSUC display large amounts of SUMO-
conjugation presumably reflective of heterochromatic regulation. The pathways and 
proteins modified by SUMO-regulations are divergent and expansive, but converge 
upon the relatively few E3 ligases, a class of co-regulators, that directly specify 
SUMO-conjugation upon many other proteins and subsequently alter their functions. 
Clearly SUMO is involved in regulation of meiosis, but its effect and the co-regulators 
which drive its conjugations remain an unexplored frontier in the biology of meiosis. 
 Hypothesis: CCNB1IP1 is a meiotic co-regulator; a SUMO E3 ligase 
functioning to specify SUMO-conjugates and aid to establish crossover fate 
specification in the resolution of DSB repair intermediates. 
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CHAPTER 2 
 
Evidence implicating CCNB1IP1, a RING domain-containing protein required for 
meiotic crossing over in mice, as an E3 SUMO ligase 
 
*Reprinted from: Strong, Edward R., and John C. Schimenti. "Evidence Implicating 
CCNB1IP1, a RING Domain-Containing Protein Required for Meiotic Crossing Over 
in Mice, as an E3 SUMO Ligase." Genes 1.3 (2010): 440-451. Creative Commons 
Attribution License 
  
Abstract 
The RING domain-containing protein CCNB1IP1 (Cyclin B1 Interacting 
Protein 1) is a putative ubiquitin E3 ligase that is essential for chiasmata formation, 
and hence fertility, in mice. Previous studies in cultured cells indicated that 
CCNB1IP1 targets Cyclin B for degradation, thus playing a role in cell cycle 
regulation.  Mice homozygous for a mutant allele (mei4) of Ccnb1ip1 display no 
detectable phenotype other than meiotic failure from an absence of chiasmata. 
CCNB1IP1 is not conserved in key model organisms such as yeast and Drosophila, 
and there are no features of the protein that implicate clear mechanisms for a role in 
recombination. To gain insight into CCNB1IP1’s function in meiotic cells, we raised a 
specific antibody and determined that the protein appears at the onset of pachynema. 
This indicates that CCNB1IP1 is involved with crossover intermediate maturation, 
rather than early (leptotene) specification of a subset of SPO11-induced double strand 
breaks towards the crossover pathway. Additionally, a yeast 2-hybrid (Y2H) screen 
revealed that CCNB1IP1 interacts with SUMO2 and a set of proteins enriched for 
consensus sumoylation sites. The Y2H studies, combined with scrutiny of CCNB1IP1 
domains, implicate this protein as an E3 ligase of the sumoylation cascade. We 
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 hypothesize CCNB1IP1 represents a novel meiosis-specific SUMO E3 ligase critical 
to resolution of recombination intermediates into mature chiasmata. 
 
Introduction 
In previous work, our lab conducted forward genetic mutagenesis screens to 
identify novel genes required for meiosis in mice [1, 2]. One of the alleles, mei4, 
presented as a recessive male and female sterile.  Histological and cytological analyses 
revealed abnormal alignment and distribution of chromosomes at metaphase/anaphase 
at the first meiotic division in spermatocytes and oocytes [3].  Immunocytological 
analyses revealed no abnormalities in non-crossover (NCO) recombination or 
chromosome synapsis through early pachynema. However, as the meiocytes entered 
diplonema, the homologous chromosomes failed to maintain interhomolog 
associations, suggesting an absence of chiasmata.  This suspicion was confirmed by an 
absence of MLH1 and MLH3 foci on pachytene chromosomes  [3].  The mismatch 
repair proteins are well established markers of chiasmata  [4].   
Positional cloning revealed that mei4 is a mutant allele of Ccnb1ip1 (also 
called Hei10), a gene not previously known to have a role in meiosis. Ccnb1ip1 
encodes a coiled-coil RING domain-containing protein. Studies of CCNB1IP1 in 
cultured somatic cells implicated a role for this putative ubiquitin E3 ligase in Cyclin 
B regulation, cell cycle progression, and cell invasion [5-7].  However, the exact 
function of CCNB1IP1 in meiotic recombination remains is unclear.  A model 
proposed by Ward et al posited that CCNB1IP1 disrupts association of CDK2 with 
CCNB3, possibly via ubiquitylation, thus permitting CDK2 to recruit or enable 
binding of MLH1 and MLH3 (and possibly other proteins) to designated crossover 
sites  [3].  
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 To better understand the role of CCNB1IP1 in recombination, and to gain 
possible support for the aforementioned model, we conducted a yeast two hybrid 
(Y2H) screen for interacting proteins in the mouse testis, characterized the temporal 
appearance of CCNB1IP1 during meiosis, and examined bioinformatically the domain 
structures of CCNB1IP1.  Surprisingly, these studies implicate CCNB1IP1 as a 
SUMO (Small Ubiquitin-like Modifier) E3 ligase.  SUMOylation modulates many 
behaviors of proteins, including interactions with other proteins, subcellular 
localization, and stabilization though competition with Ubiquitin for lysine 
residues  [8]. The process of SUMO conjugation to target substrates is analogous to 
that of the well characterized Ub cascade; involving E1, E2 and E3 type ligases  [9]. 
The role SUMO plays in meiosis remains largely unknown; however, 
immunolocalization studies in the mouse have detected SUMO at sites of DSBs and at 
centromeric and heterochromatic regions.   Additionally, the singular SUMO E2 
ligase, UBC9 (UBE2I in the mouse) localizes along synapsed chromosome cores 
during pachynema and diplonema  [10, 11]. The evidence we present in support of 
CCNB1IP1 as a potential SUMO E3 ligase has the potential to reveal hitherto 
unknown mechanisms in mammalian meiotic recombination. 
 
Results and Discussion 
Expression of CCNB1IP1 and CCNB1IP1mei4 during spermatogenesis 
CCNB1IP1 is essential for meiotic crossing-over in mice.  In S. cerevisiae, 
although double Holliday junctions characteristic of crossover (CO) recombination 
appear in early-mid pachynema  [12], the partitioning of double strand breaks (DSBs) 
to either the NCO or CO pathways is made much earlier, in late leptonema  [13].  Like 
yeast, mammals have genetically distinct NCO and CO pathways  [14].  Therefore, 
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 CCNB1IP1 may be required either for the specifying a subset of DSBs to the CO fate 
in leptonema, or subsequent processing of CO recombination intermediates in 
pachynema. 
As a first step towards addressing this question, we generated an affinity-
purified rabbit polyclonal antibody against N-terminal amino acids 1-245 of 
CCNB1IP1.  The antibody recognized a protein slightly larger than 30kDa (theoretical 
MW of CCNB1IP1 = 32kDa) in Western blots of WT protein from 20 dpp and adult 
mouse testis.  Juvenile Ccnb1ip1mei4/+ extracts had roughly half the amount of the 
32kDa species compared to WT animals. The 32kDa species was completely lacking 
in homozygous mutants, consistent with it being CCNB1IP1 (Fig. 2.1a). Notably, both 
heterozygous and homozygous testis extracts showed an additional, slightly smaller 
band on the Western blots (Fig. 2.1a,b). This species was not as robust as wild-type 
CCNB1IP1, and it appeared to be more predominant in the homozygous mutants than 
in heterozygotes. Considering that the Ccnb1ip1mei4 allele is predicted to encode a 
protein bearing an internal deletion of 24 amino acids (~2.7 kDa) [3], it is likely that 
the smaller species in the Western blot is this truncated protein. The mutant 
CCNB1IP1 allele may retain some function. However, the relatively lower amounts of 
the smaller species in both hetero- and homozygotes suggests that the CCNB1IP1mei4 
protein is less stable, more rapidly cleared, or translated at a lower efficiency than WT 
CCNB1IP1. 
To further confirm the specificity of the antibody, we performed Western blot 
analysis of protein from 20 dpp testis extracted from several meiotic mutants (Fig. 
2.1b). The 32kDa product is undetectable in Ccnb1ip1mei4/mei4 animals, but was present 
in mice homozygous for a mutant Mybl1 allele that causes meiotic arrest at a stage of 
meiosis similar to that of Ccnb1ip1Mei4 spermatocytes (late pachynema/diplonema; 
unpublished). This result indicates that the 32kDa species is not a cross-reactive  
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Figure 2.1. Western blot analysis of CCNB1IP1 expression in testis. 
(A) Polyclonal anti-CCNB1IP1 recognizes a ~32kDa species in 20dpp testis of WT 
and heterozygous Ccnb1ip1
mei4
 animals.  This band is absent in mutants (third 
lane), but a lower band of ~30kDa is evident that not present in WT. (B) 
CCNB1IP1 is greatly decreased or absent from mutant testes that undergo meiotic 
arrest prior to pachynema (Mei1
-/-
), but not those that progress to approximately 
diplonema (Mybl1
-/-
). (C) CCNB1IP1 in testis is first produced between days 13 
and 15 dpp, coincident with onset of pachynema. 
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 product from a class of cells that are missing in Ccnb1ip1mei4/mei4 testes.  The product 
was present at low levels in Mei1/Mei1 20 dpp testis, in which meiosis arrests prior to 
entry intopachynema due to failed DSB formation and extensive asynapsis  [15, 16]. 
This suggests either that Ccnb1ip1mei4 expression is either dependent upon DSB 
formation (which occurs in leptonema), or it initiates in pachytene spermatocytes. 
To pinpoint the onset of CCNB1IP1 production, we took advantage of the 
coordinated first wave of spermatogenesis after birth.  Leptotene, pachytene, late 
pachytene and diplotene cells appear en masse approximately 10, 14, 18, and >18 dpp, 
respectively  [17, 18].  As shown in Figure 2.1c, CCNB1IP1 is absent in 13 dpp testis 
and appears at 15 dpp coincident with spermatocyte entry into pachynema. CCNB1IP1 
then persists throughout adulthood, although the data does not indicate if it is present 
in postmeiotic spermatids.  These data indicate that CCNB1IP1 is not involved in 
partitioning DSBs to the CO pathway.  Rather, expression after entry into pachynema 
suggests a requirement for processing CO recombination intermediates. 
 
Identification of CCNB1IP1 interacting proteins 
CCNB1IP1 is a coiled-coil RING domain-containing protein shown to have E3 
Ubiquitin ligase activity  [5]. The RING domain is characteristic of the E3-ligase 
family of proteins. To identify potential ubiquitylation targets of CCNB1IP1 and other 
interacting proteins that might illuminate the molecular mechanism by which this 
protein participates in crossing over, we conducted a yeast two-hybrid (Y2H) screen of 
a testis library (Fig. 2.2). Full length CCNB1IP1 was found to be auto-activating under 
the selective growth conditions of the screen.  Progressive C-terminal truncations 
narrowed the autoactivating region to that containing 2 putative Cyclin/Cdk target 
motifs [5], so these were deleted from the bait vector. Thirty-five interactors were  
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Figure 2.2. Yeast two-hybrid screen for CCNB1IP1 interacting proteins in the 
testis. 
(A) Structure of CCNB1IP1 and known motifs/domains.  A C-terminal truncated 
construct was used as bait (∆ct). This lacks two potential phosphorylation sites of 
cyclin/cdk kinases. A bait construct with the deletion contained in the Ccnb1ip1
mei4
 
allele (mei4∆ct) is shown at the bottom. (B) Confirmation of prey clones under 
maximal selection stringency (ade and his) with leu and trp selection for presence 
of bait and prey plasmids.  (C) Growth of yeast containing 4 different prey and 
either the ∆ct bait or the mei4∆ct bait.  A subset of CCNB1IP1 interactors 
(asterisks) were found to reproducibly display weaker interaction with mei4∆ct 
than ∆ct, as assessed by vigor of individual colony growth.  Ø=empty vector; a = 
EP400; b = OAZ3; c = 5730469M10Rik; d= 4930455F23Rik. 
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 isolated and validated (Table 2.1; see Methods). Literature review and database 
searches reveal that none of the CCNB1IP1 interacting genes are known to be 
essential for meiosis; however, manual survey of the NCBI GEO Profiles database 
reveals several are transcriptionally up-regulated in the testis, with postnatal testis 
expression increasing in age and peaking during pachytene of meiosis I (accessions 
GDS3142, GDS605, GDS401).  
In light of the Western blot data indicating that Ccnb1ip1mei4/mei4 testes 
produced a deleted version of CCNB1IP1, we hypothesized that the mutant protein 
might have defective interactions with some subset of the Y2H binding partners, thus 
potentially explaining the recombination phenotype. We therefore tested the full set of 
35 CCNB1IP1 interactors against the mutant allele as bait (signified as mei4∆ct).  The 
Ccnb1ip1mei4 deletion did not ablate interaction with any of the prey clones, however it 
did reproducibly lead to a “kinetically” weaker interaction as assessed by colony size 
under stringent growth selection conditions (Fig. 2.2c).  If this is reflective of the in 
vivo situation in mice, it is possible that the weaker interactions, coupled with the 
decreased level of mutant protein, contributes to the phenotype. 
Conspicuous amongst the Y2H interactors was SUMO2. This prompted us to 
consider a potential role for CCNB1IP1 in the SUMOylation cascade. Inspection of 
the other CCNB1IP1 interacting proteins revealed one notable common motif: Ψ-K-X-
E/D (where Ψ is a hydrophobic amino acid; Table 2.1). This Ψ-K-X-E/D motif is 
enriched in targets of SUMOylation, and lysine (K) is the residue targeted for SUMO 
modification in those proteins  [19, 20].  Notably, of the 13 proteins with kinetic 
defects in interaction affinity for mei4∆ct, 7 (54%) carry the SUMOylation motif with 
5/7 possessing the most common form Y/L-K-X-E.  The predicted SUMO-proteome 
has been estimated to be 38% of all similarly analyzed peptides  [21]. 
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Kinetically normal 
with MEI4Δct 
Kinetically defective 
with MEI4Δct 
SUMO2 4930455F23RIK  
AKAP9  YPEL2  
SPINK10  1700006A11RIK  
1700019N19RIK  EP400 
POLR2B POMP  
ENAH MSL1  
H3F3B DDC8  
5730469M10RIK HOOK1  
PHF12 GGN  
MRRF  FHL5  
OCIAD1  4930503B20RIK  
B9D1  1700021F07RIK  
MORN2  SPATA3  
ATOH8   
SRGN   
PENK1  
BRP44  
INSL3  
EMX1  
GSG1   
OAZ3  
MIIP  
 
Table 2.1. Proteins Identified in Two Hybrid Screen. 
Proteins with predicted SUMOylation sites are underlined.  All clones for the 
corresponding proteins were isolated with CCNB1IP1Δct as bait.  Later they were 
individually tested for interaction with the MEI4 deletion version. They were 
subdivided into two kinetic interaction classes as indicated by the two columns. 
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 Motif analysis of CCNB1IP1 implicates it is a SUMO E3 ligase 
PIAS4 and other SUMO E3 ligases have been found to interact with SUMO in 
Y2H assays  [22, 23, 24]. Given that CCNB1IP1 interacts with SUMO2 and other 
proteins containing consensus SUMOylation sites, we hypothesize that CCNB1IP1 
has SUMO E3 ligase function in addition to its reported E3 Ub ligase activity.  SUMO 
E3 ligases often contain a C3H2C3 type RING domain believed to confer interaction 
specificity to the singular known E2 ligase, UBC9  [25, 26]. Alignment of CCNB1IP1 
from mouse and other species as well as known SUMO E3 ligases (ZIP3, SIZ1, SIZ2) 
reveals the presence and conservation of a C3H2C3 type RING domain.  Additionally, 
non-covalent SUMO interacting motifs (SIMs) have been identified within most 
SUMO E3 ligases  [26, 27, 28]. SIMs are characterized by Ψ-X-Ψ-Ψ where Ψ is V/I 
or another large hydrophobic residue  [27, 29].  CCNB1IP1 indeed has such a 
sequence conserved across mammals (Fig. 2.3b; non-human mammals not shown).  
This putative SIM is just 15 aa residues N terminal to the deletion in the 
Ccnb1ip1mei4 allele (Fig. 2.3b).  Recently, studies of the Pc2 SUMO E3 ligase showed 
that pairs of charged and hydrophobic amino acids adjacent to the consensus SIM 
facilitate E3 function [28].  These residues have been proposed to facilitate 
interactions with SUMO-conjugated UBC9 [29].  The deletion immediately C-
terminal to the putative CCNB1IP1 SIM, if it contains similar facilitating residues, 
may impair interaction with UBC9-SUMO in vivo. 
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Figure 2.3. SUMO E3 ligase-like domain conservation in CCNB1IP1. 
(A) Alignments of C3H2C3-type RING domains in four CCNB1IP1 orthologs and 
other known SUMO E3 ligases.  (B) CCNB1IP1 contains a canonical SIM motif 
(blue) just upstream of the region deleted in the Ccnb1ip1
mei4
 allele. 
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 Conclusions 
CCNB1IP1 is required for crossing-over, but there is no known mechanistic 
linkage to recombination.   We conducted the Y2H screen in the hope of identifying 
proteins of known function that might provide such mechanistic linkage. Although 
none of the identified interacting proteins have reported roles in crossing-over, our 
analyses of the aggregate Y2H data suggest a function for CCNB1IP1 as an E3 ligase 
in the SUMO modification pathway. To summarize, we found that CCNB1IP1 
interacts with both SUMO2 and proteins containing the consensus SUMOylation 
motif, properties consistent with computational studies of SUMO E3 ligases  [21, 24, 
30].  Furthermore, we observed that CCNB1IP1 contains a C3H2C3 type RING 
domain, conserved in proven SUMO E2 ligases, that constitutes the interaction surface 
with the SUMO E2, UBC9.  Finally, CCNB1IP1 contains a consensus SIM domain 
found in the majority of characterized E3s.  This sequence has been proposed to 
function in aiding E3 interaction with SUMO-conjugated UBC9 (not unconjugated 
UBC9)  [31, 32]. Whether the putative SIM in CCNB1IP1 actually functions in this 
manner awaits experimental validation. 
There is increasing evidence indicating multiple roles for SUMO modification 
in regulating DNA repair and meiosis.  The S. cerevisiae SUMO E3 ligase Zip3 
ensures that SC formation is dependent on recombination initiation, and it interacts 
with a number of recombination proteins including Mre11, Rad51, Msh4 and 
Msh5  [26, 33, 34]. The Zip3 ortholog in C. elegans is required for meiotic crossover 
formation and is localized to sites of crossing-over in late Prophase I  [35].  Variants in 
the human ortholog RNF212 have been associated with influencing genome-wide 
meiotic recombination rates  [36, 37].  Furthermore, the synaptonemal complex 
component protein Zip1 and axial-element protein Red1 have been demonstrated to 
bind SUMO-conjugated proteins, the latter of which promotes interhomolog 
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 exchange  [26, 38].  Finally, the SUMO pathway is involved in regulating 
ubiquitylation in DNA damage responses in mammalian cells  [39, 40]. 
These results, together with the growing understanding of SUMOylation in 
higher order eukaryotes, are beginning to shed light on the role for SUMO in DNA 
damage responses and recombination in meiosis. The defect of Ccnb1ip1mei4 in 
meiotic crossing over and its putative role as a SUMO E3 ligase offer us a novel 
element in our understanding of the mechanisms regulating crossover formation.  The 
result of the Y2H screen, which identified a number of putative SUMOylation target 
proteins with no known roles in meiosis, suggest that further study of CCNB1IP1 will 
reveal novel mechanisms of meiotic recombination in mammals. 
 
Materials and Methods 
Recombinant expression of CCNB1IP1 and anti-CCNB1IP1 production. 
cDNA corresponding to amino acids 1-245 of CCNB1IP1 was subcloned into 
expression plasmid pQE-30 (Qiagen), so as to add a 6X HIS tag. Bacterially expressed 
peptide was solubilized using standard procedures with the addition of 5M Urea. The 
HIS-tagged peptide was purified on a HisPur cobalt resin column according to 
manufacturer’s protocols (Pierce). The peptide purification was verified via SDS-
PAGE and concentrated on a Vivaspin 15R column (SartoriusStedim). The purified 
CCNB1IP1 was used as immunogen for polyclonal antibody production in rabbit, 
followed by affinity purification over immobilized CCNB1IP1 as per manufacturer’s 
procedures (GenScript).  Specificity of the IgG was assessed by dot-blot down to 
250pg of recombinant CCNB1IP1. 
SDS-PAGE and Western blotting. 
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 SDS-PAGE and Western blotting were performed by standard procedures. 
Tissues from mice were dounce homogenized in cold lysis buffer (1% SDS, 10mM 
EDTA, 50mM Tris, pH 8.0) supplemented with protease inhibitors (complete®, 
Roche) followed by sonication at 1s intervals for 30s. Lysates were boiled for 5min 
followed by clearing via centrifugation. Protein concentrations of cleared lysates were 
measured by the BCA protein assay (Thermo). Loading controls were performed with 
anti-β-actin following SDS/2-MeOH stripping of the PVDF membrane. CCNB1IP1 
signal was detected with 1:250 dilution of anti-CCNB1IP1 incubated 3hr at 4C 
followed by an hour incubation using goat anti-rabbit HRP-conjugated antibody.  
Yeast two-hybrid screen for CCNB1IP1 interactors 
Full length CCNB1IP1 was found to be auto-activating under the Y2H 
conditions used. Following analysis of various truncations for loss of auto-activation 
under screen conditions, cDNA of a C-terminal truncation of mouse Ccnb1ip1 
corresponding to amino acids 1-245 (encoding what we call CCNB1IP1∆ct) was 
expressed as a “bait” fusion protein with the GAL4 DNA-binding domain.  This was 
constructed in plasmid pGBK. A mouse testis cDNA library in pACT2 (Clontech) was 
used as “prey” for a protein-protein interaction screen with CCNB1IP1∆ct. 
Interactions with CCNB1IP1∆ct were selected by colony growth in the absence of 
histidine on plates supplemented with 7.5mM 3-AT. Strongly growing colonies were 
confirmed under more stringent interaction selection on plates lacking histidine and 
adenine.  pACT2 cDNA clones were isolated and analyzed by DNA sequencing. The 
CCNB1IP1∆ct interactor clones were then directly tested for interaction affinity with 
the same c-terminal truncation from Ccnb1ip1mei4 cDNA (called mei4∆ct) under the 
more stringent conditions (Fig. 2.2a). Those clones showing decreased affinity of 
interaction with mei4∆ct were confirmed in three independent experiments.
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CHAPTER 3 
 
CCNB1IP1 as a regulator of SUMO conjugation 
 
Abstract 
 The gene for Cyclin B1 Interacting Protein 1 (Ccnb1ip1) is essential in the 
mouse for meiotic crossing-over. Animals carrying an allele for a defective Ccnb1ip1 
fail to form obligate meiotic crossovers in Prophase I and present as male and female 
infertile while otherwise appearing grossly normal. I implicated CCNB1IP1 as a 
SUMO E3 ligase with function as a co-regulator of SUMOylation upon targets more 
directly involved in crossover formation. Here we present biochemical interrogations 
of CCNB1IP1 activity both in vivo and in vitro. In vitro, recombinant CCNB1IP1 
displays a propensity toward autoSUMOylation in conditions deficient for a 
subsequent final target of SUMOylation, a characteristic property of E3 ligases. In 
vivo, the previously identified interacting partners of CCNB1IP1, GGN and 
4930455F23RIK, are themselves targets of posttranslational modification dependent 
on interaction with a putative SUMO E3 ligase. Together, these studies support the 
hypothesis that CCNB1IP1 functions as a SUMO E3 ligase essential to the formation 
of meiotic crossovers. 
 
Introduction 
Genetic mutation in the mouse reveals Ccnb1ip1 as an essential factor in 
mammalian spermatogenesis. Ccnb1ip1mei4/mei4 spermatocytes arrest due to a failure to 
maintain sites of reciprocal crossing-over [1]. Previous functional studies of 
CCNB1IP1 activity in somatic cells have shown the protein to function as an E3 
adapter ligase within the well-understood Ubiquitin pathway [2]. Subsequent studies 
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 by our group have implicated CCNB1IP1 as being associated with factors in the 
SUMO (Small Ubiquitin-like MOdifier) pathway. Proteomic analysis of CCNB1IP1 
domains, including the C3H2C3-like RING domain, together with its non-covalent 
binding to SUMO2 have led us towards the hypothesis that CCNB1IP1 orchestrates 
SUMO-conjugation to target peptides as an E3 adapter ligase in spermatocytes.  
As a SUMO E3 ligase, CCNB1IP1 would present itself as a “meiotic co-
regulator”, a class of proteins that directly affect altered function upon multiple other 
proteins. In the case of CCNB1IP1 as a co-regulator, a set of its subjugates would be 
presumed to more directly impact the observed CCNB1IP1-dependent reciprocal 
crossing over within meiosis. These CCNB1IP1-regulated factors would be essential 
to faithful crossing-over, and thus physical tethering together of homologous 
chromosomes entering into metaphase of meiosis I. Failure in accurate homolog 
segregation at metaphase I clinically manifests as infertility in the adult or 
developmental defects of the fetus, underscoring the importance of crossover 
regulation in mammalian meiosis [3]. The co-regulators of cellular processes, 
including meiosis, represent single points upon which the diverse functions of many 
other proteins converge, presumably for timely and/or response-driven regulation of 
activity. Conjugation with SUMO regulates diverse functions, and the essential E3 
adapter ligase co-regulators specify the targets of SUMO-conjugation and thus 
represent one class of these convergences and coordination. While SUMOylated 
peptides have been observed in nearly all stages of spermatogenesis, identities, 
pathways, regulations, and sites of action are poorly understood. 
The covalent-modification of proteins with Ubiquitin or SUMO is an 
enzymatic action in which the modifying peptide is transferred from the respective E2 
enzyme onto the target protein. The class of E3 ligase enzymes functions as the 
adapter between the E2 and target proteins so as to regulate and increase efficiency of 
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 the modification. Hershko and Ciechanover have defined the E3 as “an enzyme that 
binds, directly or indirectly, specific protein substrates and promotes the transfer of 
ubiquitin [or similar], directly or indirectly, from a thioester intermediate amide 
linkages with proteins or polyubiquitin [or similar] chains” [4]. 
The founding members in the class of SUMO E3 ligases were first uncovered 
through yeast two-hybrid screens as proteins that interact with SUMO [5,6]. In 
structural similarity to the ubiquitin cascade, Histidine and Cysteine residues in both 
Ub and SUMO-specific E3 ligase RING fingers coordinate a pair of Zinc atoms 
forming a “cross-brace” which, in turn, builds a globular tertiary structure that can 
directly bind a specific E2 enzyme. In the SUMOylation cascade there is believed to 
be a single E2 enzyme, Ubc9/UBE2I, responsible for all SUMO-modification. This is 
thusly coincident with a dominant SP-RING type domain found in known SUMO E3 
ligases. Analogous to the ubiquitination cascade, functional tests of SUMO E3 ligases 
have shown precocious E3 auto-sumoylation, and poly-SUMO chain formation when 
adequate target protein is not present [7,8]. 
Due to a similarity of molecular response to analogous insults, particularly 
double strand breaks (DSBs), much has been previously extrapolated and validated 
from somatic- and into meiotic- DNA Damage Response (DDR). X-ray induced DSBs 
in HeLa cells result in increased levels of SUMO2 and presumably signaling DDR 
repair [9]. Such studies illuminate an alleged role for SUMO in response to genomic 
insults. Knockout studies of the sole E2 enzyme, Ubc9/Ube2i, and presumably 
ablation of the SUMO proteome underscores the essential role SUMO plays; mice 
deficient for Ube2i undergo early lethality [10]. High tertiary structural similarity 
amongst SUMO1/2/3/4, and coincident expression of SUMO1/2/3 could indicate 
functional redundancy, and indeed mice mutated for SUMO1 bear no major 
developmental or fertility defects [11]. While the SUMO peptides themselves may be 
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 redundant in function, SUMOylation is essential and plays a role in response to 
genomic insults. Studies of the DDR response in somatic cells are identifying SUMO 
targets, their roles and the E3s which specify their SUMOylation, little progress has 
been made in understanding SUMO-mediated meiotic DDR response. 
Most of what we know about SUMO, its conjugates, and the E3 ligases that 
give specificity to the system stem from studies of the PIAS family of E3-like RING 
domain proteins. In the mouse, PIAS family members represent the most well studied 
SUMO E3 ligases and have been used to identify many SUMO-substrates. PIAS4 
(PIASy) was the first PIAS to be verified as a SUMO E3 ligase of LEF1 in vitro, as 
well as unknown other substrates in vivo [12]. Likewise, as the SP-RING domain 
would suggest, all other PIAS family proteins function as SUMO E3 ligase, notably 
including PIAS1-dependent SUMOylation of P53 [13]. In yeast, Siz1 and Siz2 are the 
most closely related genes to mammalian PIAS and were identified as SUMO E3s 
through two-hybrid interaction with Smt3 (yeast homolog of SUMO), as well as in 
vitro activity [14,15].  The SP-RING derives its name from the Siz/Pias family of E3 
ligases.  
Reliable culture systems are not available for spermatogenesis and 
consequently little is known about the co-regulators and post-translational 
modifications in mammalian meiosis. Studies in yeast have identified a role for 
SUMO in meiotic regulation of SC formation and DSB repair though crossing-over 
[16]. Interrogations of these events, and discovery of higher order SUMOylation has 
been hindered by cell type, low detection levels of SUMO-conjugates, and technical 
differences in antibodies. While gross-detection of SUMO-conjugates has shown 
selected localization to Prophase I heterochromatin and centromeres, UBC9/UBE2i is 
seen to localize in a purposeful manner along the length of the SC and studies from the 
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 human have shown SC proteins SYCP1 and SYCP2 are SUMOylated in 
spermatocytes [17-19].  
While not much is understood about the effective nature of SUMO-conjugated 
proteins in meiotic recombination, a few well-established factors shared between 
mitotic and meiotic recombination are identified as part of the SUMO proteome. The 
yeast DNA helicase Sgs1 (commonly called BLM in mammals) is involved in both 
mitotic and meiotic joint molecule resolution and is SUMO-regulated [20,21]. Two-
hybrid studies have shown physical interaction between the marker of early 
recombination initiation, RAD51, and the SUMO E2 ligase in humans [22]. The 
potential consequences of this interaction are unknown but may indicate that 
SUMOylation plays a role in the processing of DSBs in accord with the observed 
SUMOylation of Lim15/Dmc1 in Coprinus cinereus [23]. Concurrent with the 
observation of SUMO-conjugates at centromeres in mammalian spermatocytes, yeast 
Smt3/SUMO localizes to meiotic centromeres and is hypothesized to facilitate 
nucleation and further polymerization of SCs [24-26].  
Meiotic recombination is facilitated by the physical tethering together of 
homologous chromosomes through the proteinaceous Synaptonemal Complex (SC). 
While research has revealed several essential components of this proteinaceous 
structure, there is a lack of thorough understanding of the quaternary structure and the 
nature of the protein-protein associations building the SC. Biochemical studies of 
known SC constituents have revealed a propensity for these proteins, notably those of 
the Transverse Filament, under conditions non-suitable for native SC assembly to self-
assemble into SC-like aggregates known as polycomplexes [27-30]. The propensity to 
build SC-like structures and the consistent localization of SUMO peptide to these 
structures underscores the essential role SUMO is hypothesized to play in meiotic 
progression. This possibly indicates that SUMO plays a role in facilitating protein-
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 protein interactions and assembly of proteinaceous structures facilitating DDR.  It is 
interesting that many of the identified Central Element and Transverse Filament 
proteins contain coiled-coil domains, since such domains are known to facilitate 
homo- and hetero- protein-protein interactions [31]. Presumably often mediated 
through coiled-coil domains, under events of native SC assembly failure, 
polycomplexes may be the manifestation of an intrinsic action for Central Region and 
Transverse Filament proteins to self-assemble into SC-like structures. 
Informed by the secondary and tertiary structural predictions of CCNB1IP1, 
together with the previously reported two-hybrid data, I set forth to understand the 
biochemistry of CCNB1IP1 interactions and functions. I hypothesized that 
understanding the functional biochemistry of domains within CCNB1IP1 would 
complement the existing hypothesis of meiotic SUMOylation and SC localized 
proteins as well as builds the foundation upon which to understand the targeted role of 
CCNB1IP1-dependent SUMOylation upon specification of crossing-over. 
 
Results 
CCNB1IP1 ectopic expression forms polycomplex-like structures.  
CCNB1IP1 has been previously hypothesized to function in cell cycle 
regulation, mediated though it’s C-terminal CDK-like domains. Furthermore, due its 
essential role in Prophase I progression, formation of crossing-over, and its 
hypothesized role as SUMO E3 ligase together in context to the known localization of 
SUMO-conjugates at heterochromatic DNA, and UBE2I localization to condensed 
meiotic cores of Pachynema, I suspected CCNB1IP1 localization in the nucleus or 
upon the chromatin itself.  
My previously generated custom antibody against CCNB1IP1 proved 
unsuccessful with immunolocalization on both fixed tissue sections and disassociated 
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 spermatocytes (data not shown). Faithful tissue culture of meiocytes has thus far 
proved unsuccessful. Due to this, I implemented ectopic expression of fluorescently-
tagged CCNB1IP1 in the well-defined CHO and HEK293 cell lines. The complete 
coding sequence of Ccnb1ip1 was cloned into pmCherry-N1, and expression was 
driven though the CMV promoter (fig. 3.1a). In both transient transfections and stably 
selected lines of CHO and HEK293 cells, CCNB1IP1 was observed to self-
interactions into long filamentous structures, as visualized through fluorescent 
microscopy of the mCherry tag (fig. 3.1b). Clonal selection for stable lines expressing 
CCNB1IP1mCherry yielded homogenous populations, indicating that these structures 
were cell-cycle independent. 
 The formation of CCNB1IP1 filamentous structures is reminiscent of the 
“polycomplexes” formed by aggregation of SYCP3 and SYCP1 upon similar ectopic 
expression [28,30]. In both cases, ectopic expression of DNA-directed, synaptonemal 
complex-associated proteins aggregated into thin fibers which then further associated 
and appeared to build thicker fibrous structures. These self-assembling arrays have 
been termed “polycomplexes” and have been thought to be an indicative characteristic 
of synaptonemal complex associated proteins, possibly reflecting storage of excess 
SC-associated components [30,32]. 
Previous studies of mine and other labs found the full length isoform of 
CCNB1IP1 to be autoactivating to Y2H systems, as well as difficult to express in the 
soluble fraction of recombinant protein production (discussed later). I considered that 
these observations may be related to the self-assembly of fibrous networks as seen in 
the ectopic cell culture expression system. My previous expression attempts in yeast 
(for two-hybrid) and in bacterial cells (for recombinant protein production) 
demonstrated that the protein could be faithfully expressed when the c-terminal tail, 
including putative CDK-like domains, was truncated. My two-hybrid experiments  
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A 
B 
CCNB1IP1mCherry 
Figure 3.1. CCNB1IP1 ectopic expression in cultured cells. 
Towards understanding the localization and biochemistry of CCNB1IP1, fusion 
alleles of CCNB1IP1 were expressed in CHO and HEK293 under control of the 
CMV promoter. (A) mCherry is C-terminally tagged to full-length CCNB1IP1 so 
as to maximize distance from N-terminal RING and SIM domains. (B) 
Expression of Ccnb1ip1
mCherry
 results in dense filament formations as observed 
through mCHERRY fluorescence in live CHO cells. Filamentous structures are 
reminiscent of polycomplex formations. (C and D) C-terminal truncations of 
CCNB1IP1 were able to abolish polycomplex formations in HEK293 cells. 
Abrogation of polycomplex-like filaments may be due to removal of an 
uncharacterized homodimerization domain on the c-terminal, or resultant from 
the bulky mCherry tag’s proximity/disruption to the known homodimerization 
domain of coiled-coil domain. (E) CCNB1IP1
mCherry
 polycomplex is cytoplasmic 
in HEK cells, fixed and nuclei marked with DAPI (blue). 
mCherry 
C mCherry 
mCherry 
∆CTmCherry 
NtermmCherry 
D 
∆CTmCherry NtermmCherry CCNB1IP1mCherry 
E 
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 would suggest that the absence of the 31a.a. on the C-terminal of CCNB1IP1 are not 
catastrophic to protein tertiary structure and the protein retained ability to form 
protein-protein interactions. Ccnb1ip1∆ct, a c-terminal truncation of CCNB1IP1, was 
cloned into the pmCherry-N1 vector (fig. 3.1c). As suspected, CCNB1IP1∆ctmCherry 
abolished polycomplex-like structure formations (fig 3.1d). Furthermore, deeper 
truncation of Cccnb1ip1, similar to that as used by other groups for two-hybrid 
studies, likewise abolished polycomplex-like formations (fig. 3.1c/d). These results, 
along with truncations of CCNB1IP1, illustrate that the extreme C-terminal is at least 
partially responsible for the protein’s self-assembly into continuous filaments. 
 
Co-expression, in vivo studies of CCNB1IP1 activity upon targets. 
 The protein targets for posttranslational modification from Ubiquitin and 
SUMO vary in expression both developmentally and in a tissue-specific manner. 
While the E3-like ligase proteins with activity in Ubiquitin and SUMO modifications 
vary in a similar manner of time and location, it is clear that the general mechanism of 
Ubiquitylation and SUMOylation is not restricted to developmental stage nor tissue 
specificity. In both variants of posttranslational modifications, the core machinery 
(Ub/SUMO, E1-, and E2- enzymes) is present in all cells and should be available in 
access for suitable E3 enzymes and the matching targets of modification. Due to the 
lack of spermatocyte cell culture techniques to in vivo interrogate CCNB1IP1 
biochemical activity, I sought to take advantage of this universally expressed 
machinery and recapitulate the interactions between posttranslational target and the 
specifying E3 ligase, CCNB1IP1. 
I proceeded to co-express CCNB1IP1mCherry with previously identified putative 
protein conjugates, in vivo, as targets of CCNB1IP1-dependent targets of Ubiquitin or 
SUMO modification (fig 3.2a). As a putative E3 ligase of the SUMOylation cascade, I  
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Figure 3.2. in vivo co-expressions of CCNB1IP1mCherry and putative interactors. 
(A) Interactions between CCNB1IP1 and putative partners was attempted in 
HEK293 cells. CCNB1IP1 function as an E3-type ligase should target peptides to 
receive posttranslational modification. (B) Alignment of human and mouse SUMO 
E2 ligases (UBE2I) show exact conservation suitable for interspecies interaction 
with SUMO E3 ligases. (C) A selection of putative CCNB1IP1 targets were N-
terminally fused to GFP and expression driven by the CMV promoter. (D) HEK293 
cells with homogenous stable expression of CCNB1IP1
mCherry
 were transfected with 
the indicated putative targets, (E) however co-immunoprecipitations against 
CCNB1IP1 were unable to detect interactions with putative targets (as assessed by 
Western blot for associated fluorescent tag, as indicated at bottom of the blot). 
Failure to detect interaction likely owing to the polycomplex obscuring domains. 
CCNB1IP1mCherry pInteractorXDest53 
P.T.M.? 
A 
B 
C pInteractorXDest53 CMV GFP InteractorX pA 
D 
E 
50 
37 
25 
75 
20 
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 suspected some of the previously reported interacting partners of CCNB1IP1 would 
represent true targets for SUMO modification in a CCNB1IP1-dependent manner. 
CMV promoter-driven GFP-labeled putative targets of CCNB1IP1-mediated 
SUMOylation were transiently transfected into CHO and HEK cells with stable 
ectopic expression of CCNB1IP1mCherry (fig. 3.2c-d). Total cell lysates were assessed 
by Western blot to detect levels of protein expression and retarded migration due to an 
increased size dependent upon posttranslational modification. Unfortunately, likely 
owing to obscured interaction domains resultant to the in vivo aggregations of 
CCNB1IP1mCherry, interactions between CCNB1IP1 and its previously identified 
associates of protein-protein interaction were unable to be co-immunoprecipitated (fig. 
3.2e). 
 
Reconstituted CCNB1IP1-dependent SUMOylation using recombinant peptides, in 
vitro. 
 Due to the problems encountered from the lack of spermatocyte culture 
systems and dense fibrous filament formation of CCNB1IP1 ectopic expression in 
alternative somatic culture systems, I sought to recapitulate the SUMOylation function 
of CCNB1IP1 in vitro. The core components (SUMO peptides, E1-, and E2- enzymes) 
are readily obtained as recombinant proteins, and the enzymatic modification of 
SUMO to peptides can be recapitulated in vitro as an ATP-dependent reaction. 
Previous studies have used similar in vitro reconstitutions and shown that E3 ligase 
members of the SUMO cascade will both autoSUMOylate in high concentrations as 
well as increase the kinetic efficiency of target protein modification by the SUMO 
peptide (fig. 3.3). Similarly to the studied processes of ubiquitination, in conditions 
where upon the SUMO cascade is active and the E2 ligase is staged and loaded with 
SUMO to be transferred to a target peptide, autoSUMOylation of the interacting E3  
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Figure 3.3. Reconstituted in vitro SUMOylation. 
Reconstituted in vitro reactions of SUMOylation were established using 
recombinant proteins; human CCNB1IP1 (CCNB1IP1, 32kDa; fused with GST, 
25kDa) purchased from Abnova. (A) Supplied with the necessary constituents for 
SUMO-conjugation, terminal targets can be efficiently modified in the presence of 
the suitable E3 ligase (lower path). When the in vitro reaction lacks suitable 
terminal target of SUMO-conjugation, the E2 enzyme catalyzes transfer of SUMO 
peptide to the adjacent E3 ligase, leading to autoSUMOylation of the E3 (top path). 
(B) Recombinant human CCNB1IP1 shows MW shifts in vitro corresponding to 
SUMO2 supplementation, lacking appropriate terminal target protein. (C) 
AutoSUMOylation of recombinant human CCNB1IP1 is not dependent upon GST 
fusion, as the recombinant MEI1-GST is negative for MW shifting. (P53 is a 
known positive terminal target of SUMOylation. General anti-CCNB1IP1 cross 
reactivity in P53 and MEI1 samples, but background reactivity is low in in vitro 
reactions lacking a Protein of Interest, POI. The “*” indicates SUMO2 added to 
reaction.) 
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 ligase will be observed in the lack of a suitable terminal target. The purpose of this 
autoSUMOylation is not well understood, but it may demonstrate that the E2 has an 
intrinsic function in SUMO delivery and the E3 ligase is an adequate, although not 
ideal, target to receive SUMO. When these similar in vivo reactions are established in 
the presence of a terminal target for SUMO modification, the E2 ligase again eagerly 
transfers the SUMO peptide to lysine residues of proximal proteins. The presence of 
the suitable adaptor-like E3 ligase, which functions as a bridge between the SUMO-
loaded E2 and the terminal target, increases the kinetic efficiency of SUMO-
conjugation to targets. 
 Taking advantage of the pure reconstituted in vitro SUMOylation system, I 
used both purchased and custom-derived recombinant CCNB1IP1. Because the 
function of CCNB1IP1 either as an available target of “autoSUMOylation” or as the 
ligase adapter between E2 and the target requires proper tertiary structure folding of 
the peptide, GST fusions were used in both cases. Purification of GST-bound proteins 
reduces harvest of unfolded and aggregate peptides because purification over 
Glutathione offers the advantage that GST must be folded in its proper tertiary 
structure so as to facilitate its dimerization, which is essential to binding the 
Glutathione resin. Likewise, recombinant proteins suspected as terminal targets for 
SUMO were obtained as GST fusions. Using the complete in vitro reconstitution for 
faithful SUMO modification, the autoSUMOylation of CCNB1IP1 was tested in 
reactions lacking a canonical terminal target of SUMOylation (fig. 3.3b/c). In these 
reactions, using an unrelated peptide (MEI1) fused to GST and similarly purified, it 
was observed that CCNB1IP1 did indeed specifically autoSUMOylate. Similar 
autoSUMOylation was observed when custom CCNB1IP1-GST was harvested from 
my own small batch bacterial expressions (fig. 3.4a/b). This autoSUMOylation is  
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Figure 3.4. Reconstituted in vitro SUMOylation with custom CCNB1IP1. 
(A) Recombinant CCNB1IP1 was expressed though each pET, pGEX, pRSF, and 
pSUMO in the Rosetta(DE3) strain. Western blot expression qualifications reveal 
only a fraction of total CCNB1IP1 is found in the soluble supernatants. (B) Western 
blots of reconstituted in vitro SUMOylation with the recombinant CCNB1IP1 
reveals MW shifting and autoSUMOylation of CCNB1IP1. The high MW shifting 
is dependent upon poly-SUMO chain formation and lost in the sample supplied 
with mtSUMO2 unable to form poly-linkages. (“*” denotes samples receiving 
SUMO2; “#” denotes mutated mtSUMO2. Arrow marks free SUMO. Extreme high 
MW band, seen independent of SUMO2, may reflect oligomerization of 
CCNB1IP1 in vitro, as observed previously in vivo). (C) Detergents are unable to 
increase CCNB1IP1-GST purification efficiency in large batch preparations. The 
unbound soluble fraction of pGEX-Ccnb1ip1 expression was subjected to a second 
round of purification across Glutathione. Mild detergent, NP40, was unable to 
increase purification efficiency. Possibly indicating some level of CCNB1IP1 
oligomerization, resistant to detergent, precluding GST binding to Glutathione. 
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 consistent with CCNB1IP1’s internal lysine residues (K58, K142) predicted as 
receptive to SUMO modification. 
The presence of autoSUMOylation of CCNB1IP1 presents further evidence 
implicating CCNB1IP1 as a member of the E3 class of SUMO ligase peptides. Having 
some functional indication of CCNB1IP1 as a SUMO E3 ligase, I investigated the in 
vitro receptivity of proteins previously reported to interact with CCNB1IP1 and 
suspected as terminal targets for SUMO modifications. Similar in vitro reconstitutions 
were used in the presence of putative terminal targets from SUMO modifications. In 
these instances, so as to test the efficiency of CCNB1IP1 to specify targets for 
modification by the SUMO peptide, the addition of recombinant CCNB1IP1 was 
varied; In reactions receiving CCNB1IP1, the efficiency of SUMO conjugation to the 
terminal targets should be increased as opposed to those instances lacking CCNB1IP1. 
This would confirm that CCNB1IP1 is an efficient E3 ligase of the SUMOylation 
cascade and confirm CCNB1IP1-dependent targets of SUMO modification. 
Unfortunately, these reactions were inconclusive due to problems detecting low 
concentrations of peptide, background impurity, inactivity, and solubility (data not 
shown). Because of these technical difficulties in assaying E3-mediated SUMO-
conjugation with the available recombinant peptides, consumption of small batch 
CCNB1IP1, and failure of in vitro activity from later large batch CCNB1IP1 
purification (likely due to exceptional solubility problems; fig. 3.4c), I abandoned 
these efforts and looked to validate the targets of SUMOylation through other means. 
 
A synthetic SUMO E3 ligase posttranslationally modifies interactors of CCNB1IP1. 
 With the goal of more concretely validating CCNB1IP1 function as an E3 
ligase of the SUMO posttranslational pathway, and to examine putative targets of 
SUMO modification, I devised a method for establishing a synthetic in vivo 
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 SUMOylation system. The E3 ligase can broadly be considered as two separate units: 
the domain to recruit the E2 ligase and the domain to recruit terminal targets for 
SUMOylation. If these unit functions are separated, one can validate an E3 ligase as 
functional in the SUMO cascade if its E2-interaction domain (commonly the RING) 
can in vivo interact with UBC9/UBE2I so as to bring into proximity an unquestionable 
target of SUMOylation. Conversely, targets of SUMOylation, as suspected through 
their interaction with E3 ligase proteins, can be assayed for their receptivity if they can 
be recruited into the proximity of the SUMO-loaded E2 ligase though an 
unquestionably effective SUMO E3 ligase domain. 
 I employed inducible herterodimerization domains towards building chimeric 
proteins that can in vivo separate the functions of E3 ligase members in the 
SUMOylation pathway. The iDimerize system implements two expression vectors that 
allow for expression of genes fused to the coding sequence for the DmrA and DmrC 
peptides. The DmrA and DmrC domains have poor affinity towards each other. 
However upon addition of the A/C heterodimerizer compound, these two domains 
form a heterodimer, thus creating a physical linkage between their respectively 
attached proteins. Employing this system, I was able to separate the function of an E3 
RING domain from that of the E3’s target specifying role. By fusing the PIASI protein 
(P-RING) to the DmrC domain, a chimeric E3 can thus recruit an otherwise known 
target of SUMOylation that has been fused to the DmrA domain, in an inducible 
manner (fig. 3.5a). The P-RING-DmrC chimeric protein is then used to induce 
recruitment of suspected targets for SUMO modification that have been fused to the 
DmrA domain. Should these chimeric proteins fused to DmrA be SUMOylated when 
recruited to a physical linkage with the E2 ligase in this inducible manner, they will be 
shown to be dependent upon a SUMO E3-like mechanism and true targets for in vivo 
SUMOylation. 
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Figure 3.5. iDimerize inducible target specification; a synthetic E3 ligase. 
(A) Schematic of the iDimerize synthetic P-RING-DmcC mediated sumoylation of 
a DmrA fused putative target of SUMOylaton. Proteins of interest to be assayed as 
receptive to SUMOylation are fused to the DmrA peptide (grey square). In the 
presence of A/C Heterodimerizer (A/C-H.D.) the protein of interest is recruited to 
interact with the DmrC domain (green half circle) that has been fused to the SP-
RING domain containing SUMO E3 ligase, creating an inducible recruitment of 
targets for SUMOylation. (B) Putative targets of SUMOylation, fused to H.D. 
responsive dimerization domain DmrA, with nuclear or cell membrane directed 
localization. In response to P-RING interaction induced by A/C-H.D., MW shifting 
of GGN and 4930455F23Rik (arrows) are observed in Western blots probed for 
HA-epitope tags. 
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  Taking advantage of the endogenous SUMOylation present in HEK293 cells, 
and the transient mammalian expression granted by the iDimerize system, I moved to 
validate a subset of the CCNB1IP1 physical interactors as true in vivo targets of 
SUMO modification. Full-length clones of Ggn, Pomp, and 4930455F23Rik were 
fused to the DmrA domain and expressed chimeric proteins were directed either to a 
nucleus or cytoplasm, through a nuclear localization signal or membrane interaction 
motif, respectively. Upon induced A/C-dimerization, recruitment of the target protein 
of interest to the chimeric P-RING-DmrC, the synthetic E3 ligase should facilitate the 
posttranslational modification of the receptive target proteins. Indeed, in this synthetic 
and inducible test for SUMOylation, Western blot analysis of ectopically expressed 
proteins shows MW shifting of GGN and 4930455F23RIK peptides, which is 
indicative of posttranslational modification dependent upon physical interaction with 
the P-RING SUMO E3 ligase domain (fig. 3.5b). 
 From the development of a synthetic E3-like SUMO ligase and the induction 
of target interaction with this E3 ligase, I have shown that GGN and 4930455F23RIK 
are targets for SUMOylation when localized to the nuclear compartment. The fact that 
GGN and 4930455F23RIK are posttranslational modified in response to induced 
interaction with the RING domain of PIASI, a known SUMO E3 ligase, is cause to 
suspect the MW shifting is due to SUMOylation. Furthermore, the fact that they are 
modified mutually in the nuclear compartment, but not in the cytoplasm, is consistent 
with the expectation that this MW shifting is not an artifact of the target peptide under 
these experimental conditions. 
 
Discussion 
My previous results had implicated CCNB1IP1 as a putative E3-like ligase 
involved in the SUMOylation of a subset of protein-protein interactors. The possibility 
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 of identifying a meiotic co-regulator essential for SUMO-conjugation is exciting for 
both the immediate implication of understanding the function of CCNB1IP1, as well 
as in the longer term as a first step towards further understanding the role played by 
SUMOylation in meiotic DSB repair. While very little is presently known about the 
role of SUMO in meiosis, there are indications that similar to mitotic DNA repair, 
SUMO-conjugates are essential to DSB repair and directing repair processes. 
CCNB1IP1 contains a highly conserved C3H2C3 RING domain, a type of 
RING domain previously identified as having affinity towards the single SUMO E2 
enzyme UBE2I/UBC9. It was unfortunate that in vivo studies with CCNB1IP1 are 
hindered by want for spermatocyte culture systems, and by dense polycomplex-like 
aggregations of CCNB1IP1 when expressed in the somatic culture systems. Some 
groups have hypothesized that polycomplex structures are indicative of SC-associated 
proteins expressed in conditions restrictive to SC formation, but it has not yet been 
formally established. Another possible explanation for the polycomplex structures 
may be the intertwining of coiled-coil domains amongst individual peptides which are 
building polymers of coiled-coil proteins. Indeed, polycomplex-forming SYCP1 and 
SYCP3 are also coiled-coil domain proteins and the polycomplex may reflect that 
attribute rather than a generalized biochemical principle of SC relationships. 
Excitingly, in vitro recapitulation of the E3 biochemical activity was able to 
function in lieu of in vivo experiments. Like the in vivo attempts, in vitro activity is 
dependent upon natively folded and thus functionally accessed CCNB1IP1. GST-
fusions of CCNB1IP1 were used as a means to isolate that small fraction of 
recombinant CCNB1IP1 not sequestered to aggregates or otherwise unfolded. 
Reconstituted in vitro reactions proficient in SUMO-conjugation revealed high 
molecular weight shifting of CCNB1IP1 in the presence of SUMO2 peptide. This MW 
shifting was observed using both human CCNB1IP1 (produced in wheat germ) and 
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 my own produced mouse CCNB1IP1 (produced in e. coli), and is consistent with 
autoSUMOylation by poly-chains of SUMO2. In support of these poly-SUMO2 chain 
modifications to CCNB1IP1, the high MW shifting was nullified in reactions utilizing 
a mutated SUMO2 that was deficient for chain formations. AutoSUMOylation is a 
previously reported behavior of functional SUMO E3 ligase proteins and this result 
supports our hypothesis that CCNB1IP1 likewise functions in vivo as SUMO E3 
ligase. 
The second function of E3-type ligases is to interact with terminal targets for 
posttranslational modifications and recruit them to the E2 enzyme. Technical and 
reagent limitations restricted my ability to assay effects of CCNB1IP1 upon putative 
target SUMOylation in vitro, and polycomplex formations prevented CCNB1P1 in 
vivo studies so I set towards building a synthetic SUMO E3 ligase though which to 
inducible test target receptivity to SUMOylation. Using the DmrC dimerization 
epitope tag, I built a chimeric E3 ligase from the RING domain of PIASI. In the 
presence of a bridging compound (A/C Heterodimerizer) the DmrC domain interacts 
with a similar DmrA domain fused to the putative target of SUMOylation. Initial trials 
with this inducible system succeeded in posttranslational modifications of GGN and 
4930455F23RIK as assessed though an accompanying HA epitope tag. GGN and 
4930455F23RIK, as previously identified interacting partners with the putative SUMO 
E3 ligase CCNB1IP1, are thus themselves targets for SUMOylation. 
The identifications of GGN and 4930455F23RIK have interesting implications. 
CCNB1IP1 functions to regulate formation of intermediate Meiotic Nodules nearing 
terminal stabilization of Class I crossovers in late pachytene. Through the interaction 
with GGN there appears to be a protein-protein interaction cascade uncovered in that 
GGN additionally interacts with GGNBP1 (Gametogenetin binding partner 1) [33] and 
GGNBP1 interacts with the DSB essential factor MEI1 [Bjarte Furnes, unpublished 
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 communication]. This interaction cascade would tie together the essential role MEI1 
plays in the initiation of meiosis through DSB formation, through the yet unstudied 
GGNBP1 role in meiosis, to GGN which has recently been shown to function in 
meiotic DSB repair where haploinsufficiency results in moderate persistence of 
RAD51 in pachytene [34], and finally through to the role of CCNB1IP1 in crossover 
formation. Indeed, due to the moderate persistence of RAD51 in GGN 
haploinsufficient mice, it may be that the CCNB1IP1-directed modification of GGN is 
the mediating factor in crossover-dependent meiotic DSB repair. Likewise, it is 
intriguing to note that due to an internal coiled-coil domain to 4930455F23RIK, it has 
also received the designation as Ccdc181 (Coiled-coil domain containing 181). 
4930455F23RIK/CCDC181, like CCNB1IP1, is strongly expressed in the testis with 
transcription significantly increased between 14-18dpp [GEO profiles, NCBI] and 
may represent another SC-localized protein with functions yet unappreciated. 
Taken together, these biochemical studies of CCNB1IP1 support the 
hypothesis that it functions as a SUMO E3 ligase regulating the posttranslational 
modifications of proteins necessary towards the formation of crossing-over. As 
meiotic nodules mature, and sites of DSB repair through crossing-over are processed, 
protein density surrounding these crossovers increases in accordance with new and 
more complex protein-protein interactions. From somatic cell DNA repair, we know 
SUMO-conjugation effects both repair process choice, and fidelity. This leaves us to 
suspect that CCNB1IP1-dependant SUMO-conjugates are necessary towards the 
stabilization of meiotic DSB repair via crossing-over, and deficiency in this co-
regulation through posttranslational modification by a yet unknown number of 
SUMO-conjugates accounts for the lack of crossing over in Ccnb1ip1mei4/mei4 animals. 
 
Materials and Methods 
67 
 Western blot analysis 
 Protein concentrations were assessed with BCA kit (Pierce) as per 
manufacturer instructions. 30µg protein for cell lysates, or total protein quantity from 
in vitro SUMOylation reactions, was separated through SDS-PAGE and electro-
transferred to PVDF membrane (PALL Corporation), and probed with designate 
antibodies per standard protocols. Detection of HRP-conjugated secondary antibody 
through chemiluminescence (Pierce ECL and EMD Millipore Luminata Forte). 
Antibodies used: anti-CCNB1IP1 (GenScript: custom), anti-GFP (Millipore: 
AB3080), anti-DsRed (Clontech: 632496), anti-SUMO2/3 (Cell Signaling: 4971), 
anti-GST (Abcam: ab92), anti-HA (Sigma: H3663). 
 
Cloning of mCherry-fused CCNB1IP1 alleles 
Full length, ∆CT (bp 1-639), and Nterm (bp 1-507) cDNA sequences for 
mouse Ccnb1ip1 were cloned into the BamHI and EcoRI sites of pmCherry-N1 (gift 
from Paula Cohen’s laboratory). Vector pmCherry-N1 is derived from pEGFP-N1 in 
which the 3’ EGFP coding sequence has been exchanged for the mCherry fluorescent 
peptide. Resultant pCcnb1ip1mcherry, pCcnb1ip1∆ctmcherry, and pCcnb1ip1Ntermmcherry 
were sequence verified.  
 
Cloning of GFP-fused targets of SUMOylation 
 Full length cDNA amplified from the testis for Ddc8, Ypel2, 1700021F07Rik, 
and both the short (s) and long (s) cDNA for Oaz3 were cloned in pDONR221 
(Invitrogen, Cat. No. 12536-017), and moved into pDEST53 (Invitrogen, Cat. No. 
12288-015) using the Gateway system. Final products were sequence verified. 
 
Cell transfections 
68 
 HEK293 and CHO cells were grown in 6 well plates to approximate 50% 
confluence. Fresh complete DMEM media was added 3 hours prior to transfection 
with Transit-LT1 reagent per manufacturer’s directions (Mirus: MIR 2300). Briefly, 
2.5ug of plasmid DNA was transfect to cells in overnight incubation, followed by 
changing of media 3 hours prior to visualization or lysis.  
 
Recombinant CCNB1IP1 
Recombinant GST-fused human Ccnb1ip1 produced though wheat germ 
expression was purchased from Abnova (Cat. No. H00057820-P01). Custom GST-
fused mouse CCNB1IP1 was expressed from pGEX-6P-1 (GE Healthcare, Cat. No. 
28-9546-48) using Rosetta(DE3) e. coli cells (gift from Fabio Rinaldi). A starter 
culture was used to inoculate 500mL (Small batch production) of LB with antibiotics 
Chloramphenicol and Ampicillin. Cultures were grown with shaking overnight at 
room temperature with 50uM IPTG for expression induction. Cells were lysed though 
sonication and the soluble fraction purified over GST-Bind resin (Novagen, Cat. No. 
70541) and washed with buffer (20mM Tris pH 7.5, 300mM NaCl, 5% glycerol). 
Elution of the purified products using buffer supplemented with 10uM reduced 
Glutathione. Protein fractions were concentrated through filters at high speed 
centrifugation (EMD Millipore, UFC203024). Similar technique for 5L (large batch 
production) expression of CCNB1IP1.  
 
Recapitulated in vitro SUMOylation 
SUMOylation reaction in vitro performed as per the manufacturer’s suggested 
protocol (Active Motif, Cat. No. 40220). Briefly total 0.5ug of Protein(s) of Interest 
were used in the standard reaction, incubated at 30 C water bath for 3hrs, followed by 
quenching of the reaction with addition of 2x SDS loading buffer and boiling of the 
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 samples. Reaction products we resolved though Western blot analysis. Protein(s) of 
interest we the previously mentioned recombinant CCNB1IP1 and recombinant GST-
fused peptides for SPATA3 (Abnova, Cat. No. H00130560-P01), OAZ3 (Abnova, 
Cat. No. H00051686-P01), POMP (Abnova, Cat. No. H00051371-P01), and GGN 
(Abnova, Cat. No. H00199720-P01). 
 
iDimerize inducible heterodimerization 
Vectors and mammalian cell culture expressions for inducible 
heterodimerization followed the manufacture’s protocol (Clontech, Cat. No. 635067). 
Full-length clones of cDNA isolated from 18 day old mouse testis for Pomp, Ggn, and 
4930455F23Rik were inserted into the XbaI site of pHet-Mem1 and pHet-Nuc1. 
cDNA isolated from human cells coding for the full-length PIASI was inserted into the 
SpeI site of pHet-1. Expression vectors were co-transfected as previously described at 
a 3:1 molar ratio of pHet-1:pHet-Mem/Nuc1. 100nM of A/C Heterodimerizer 
compound was supplemented to induce dimerization 3hrs prior to harvesting of total 
proteins.
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CHAPTER 4 
 
CCNB1IP1 as a meiotic co-regulator in the regulation of non-crossover vs. crossover 
resolution of recombination intermediates  
 
Abstract 
Through largely unappreciated mechanisms, a small fraction of the hundreds of 
meiotic programed DNA Double Strand Breaks (DSBs) are selected and resolved as 
sites of genetic crossing-over. The formation of chiasmata, the physical 
representations of crossovers, are essential to tether homologous chromosomes and 
ensure accurate homolog segregation as meiocytes complete the first meiotic division. 
The mechanisms through which these crossover formations are regulated remain 
unknown, but failure brings about meiotic arrest or deleterious aneuploidy. 
CCNB1IP1 is a putative regulator of posttranslational modifications by SUMO and 
deficiency of CCNB1IP1 results in a failure to specify the obligate crossovers. Here I 
present evidence that CCNB1IP1 acts locally at the sites of maturing crossover 
intermediates, and failure of CCNB1IP1-mediated regulations results in the 
persistence of immature crossover intermediates which eventually fail and result in 
unrepaired DSBs and asynapsis immediately prior to the first meiotic division. 
 
Introduction 
Mammalian CCNB1IP1/HEI10 has been shown to act as an E3 ligase 
specifying target proteins for posttranslational regulation through ubiquitin [1] and is 
hypothesized to modify meiotic proteins through SUMOylation [2]. CCNB1IP1 
expression predominates in the gonad, and animals carrying the Ccnb1ip1mei4 allele 
present as both male and female infertile due to meiotic arrest [3]. In the 
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 Ccnb1ip1mei4/mei4 spermatocytes, recombination initiates and achieves full synapse of 
homologous chromosomes but later events specifying sites of crossing-over fail, 
which are observed though deficiency in the MutLγ complex (MLH1 and MLH3). 
CCNB1IP1 is an essential factor of meiosis, presumably targeting proteins for 
posttranslational modification, and a putative molecular regulator in the coordination 
of factors involved in the maturation of recombinogenic DNA repair. 
The specification of meiotic crossing-over is essential for the accurate 
segregation of homologous chromosomes at the first meiotic division. Dense 
proteinaceous structures, called Meiotic Nodules (MNs), form at the sites of selective 
meiotic DSBs and mature down to a few locations as the MNs grow in size and 
density to be ultimately resolved as reciprocal crossovers [4,5]. The vast majority of 
early observed MNs are resolved as gene conversion events of DNA repair but it is 
still unclear which enzymes are involved in selection of that subset which progresses 
to mature MNs as sites of DNA damage selected for crossover repair resolution. While 
the molecular basis of these MN structures are uncertain, studies in yeast have shown 
the sites of these Class I crossovers are at least partially populated by the meiosis-
specific ZMM proteins, Zip1/2/3/4, MutL heterodimer (Msh4/5), and Mer3. 
Ccnb1ip1mei4/mei4 failure to form this reciprocal Class I crossing-over may indicate 
deficiency to mature sites selected for crossing-over or an earlier failure to switch 
from gene conversion repair to reciprocal recombination. 
Although there are many open questions regarding the signaling and enzymes 
involved in meiotic DSB repair switching between gene conversion and reciprocal 
crossing-over, looking towards somatic cell repair of DSBs gives some insight into the 
role SUMOylation might play. In somatic cells insulted by DSBs, both ubiquitin and 
SUMO are found directly at the sites of DSBs [6,7]. In particular, all three major 
SUMO isoforms (SUMO1/2/3) are observed immediately following DSB insults [7,8]. 
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 The coincident localization of SUMO1/2/3 may be further indication of their putative 
functional redundancy, and their recruitment to DSBs is consistent with observations 
that SUMO-conjugation can act as a molecular scaffold from which to promote 
protein-protein interactions and thus alter functions or recruit additional factors.  
As MNs mature and grow in complexity towards resolving as sites of crossing-
over, the MutS homologs MSH4 and MSH5 colocalize and function to facilitate 
homology-driven alignment, synapse and resolution as crossing-over. The MSH4-
MSH5 heterodimer stabilizes D-loop intermediates and the maturation of their sites of 
localization coincides with those sites selected towards crossing-over. Failure in 
crossover intermediate maturation results in failure of MSH4-MSH5 dependent 
recruitment of the MLH1-MLH3 dimer and thus failure in crossover mediated repair 
of DSBs. The phosphorylation of the histone variant H2AX acts as an indirect marker 
of DSB damage. Phosphorylation of ɣH2AX is readily observed at the sites of DNA 
damage and persistence of ɣH2AX is indicative of failure to repair meiotic DSBs. 
With the observations of SUMO-conjugates localized to mitotic DSB repair as 
well as meiotic bodies in the human, it is not surprising that closer examination of 
spermatocytes in the mouse has revealed similar patterns of localizations of SUMO. 
Detailed examination of surface-spread meiotic nuclei has revealed SUMO1 and 
SUMO2/3 localizations to the heterochromatic- XY body and chromocenters of 
pachytene and diplotene spermatocytes, with SUMO2/3 remaining detected at 
centromeres of metaphase I [9]. Subsequent studies in mouse spermatocytes finely 
timed SUMO1 localization to precede ɣH2AX localization to the XY in zygotene 
(SUMO2/3 was not observed in zygotene) suggest a role for SUMO in Meiotic Sex 
Chromosome Inactivation (MSCI) or possibly the wider Meiotic Silencing of 
Unsynapsed Chromatin (MSUC) [10]. Further evidence of intersecting roles of 
SUMOylation in meiosis localized the conjugate to sites of DSBs in leptotene and 
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 zygotene spermatocytes, similar to the patterns of ɣH2AX and the DNA repair protein 
BRCA1 [11]. In agreement with the observed localization of SUMO to sites of 
genomic insult, proteomic efforts to identify SUMO-conjugates have built an 
“integrated SUMO functional map” in which DDR and chromatin remodeling are the 
top functional categories for SUMO-conjugates [12]. 
 Ccnb1ip1mei4/mei4 was identified in a genetic screen for infertility mutants [13]. 
Animals homozygous for this allele display meiotic failure in diplotene, as 
homologous chromosomes fail to remain associated due to lack of physical tethering 
from reciprocal crossing-over [3]. While originally identified as specific to chordates, 
subsequent genetic studies of the genes responsible for reproduction in other 
organisms have identified distant homologues of Ccnb1ip1/Hei10 in Arabidopsis and 
Japonica [14,15]. These studies in plant species seemingly confirm a role for 
CCNB1IP1/HEI10 in DSB repair fate specification through crossing-over; HEI10 foci 
localize prior to synapsis but after axial formation, and HEI10 localization eventually 
decreases to a few foci co-localizing with MLH1 at chiasmatic sites [14,15]. The co-
localization of HEI10 and MLH1, together with quantitative analysis of residual 
crossovers in hei10-/- rice, supports the previously reported phenotypes in mouse and 
CCNB1IP1’s essential role in specifying interference-sensitive class I crossing-over 
[15,14,3]. Genomic analysis of hei10 in the plant concludes that it is the ortholog of 
the well-studied yeast SUMO E3 ligase SC-promoting protein Zip3 [14,15]. This 
genomic analysis leads the authors to hypothesize that Cccnb1ip1/Hei10 is a member 
of the Zip3 family of E3 ligases, including Rnf212 and Mer2. In further support of this 
Zip3 protein family, studies in c. elegans have shown early ZHP-3/Zip3 localization 
along the length of the chromosomes is processed down to a few foci marking the sites 
of crossover recombination, reminiscent of the HEI10 patterns in plants and RNF212 
in the mouse [16]. Furthermore, these ZHP-3 isoforms in the worm are able to 
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 properly form crossing-over but fail to resolve and ensure faithful segregation of 
homologs in MI, a phenotype similar to SMO-1/SUMO mutants in that organism. This 
is further evidence of the dependent-relationship of SUMO E3s, SUMOylation, and 
crossing-over [17] A Zip3 family of E3 ligases presents interesting prospects for 
identifying the meiotic co-regulators responsible for SUMOylation signals observed at 
DSBs, SCs, and sites of crossing over. 
 
Results 
CCNB1IP1 dynamics and localization in Prophase I of meiosis. 
Having interrogated the biochemical activity of CCNB1IP1 and observed its 
characteristic to form polycomplex-like structures and the genetic defect to specify 
sites of crossing over in Ccnb1ip1mei4/mei4 animals, I suspected CCNB1IP1 would 
localize to chromosome cores of Prophase I. Having previously been reported 
essential to the formation of meiotic crossing-cover [3], I was curious to observe if 
CCNB1IP1 would localize the terminal sites of crossing-over or if localization might 
reflect a more intermediate role in maturation of DSB repair through crossover. 
Localization of CCNB1IP1 to the synaptonemal complex itself would confirm that the 
protein is in vivo recruited to the same domains as UBE2I/UBC9, and may play a 
direct role in stabilizing components of the meiotic nodules though SUMO 
attachments, presumably facilitating complex protein-protein interactions by offering 
an additional surface through which to build protein complexes upon. 
To obtain fine resolution localization of fixed proteins, I examined surface-
spread spermatocyte nuclei. The fixed cells were disassociated, settled onto slides, and 
hypotonic swelling affords for separation of chromosomes for fine resolution immune-
based localization of proteins of interest. Antibodies generated to recognize 
CCNB1IP1 were used to probe against these chromosome spreads, and fluorescent 
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 conjugated secondary antibodies were used to visualize the localization of CCNB1IP1. 
In agreement with my expectation of DNA- or SC-directed localization, CCNB1IP1 is 
observed to form discrete foci along the chromosome cores (fig 4.1). These foci are 
most numerous during pachytene as chromosomes have paired and remaining DNA 
damage is being specified for class I vs. class II repair. As meiosis progresses and the 
final sites for crossing-over are specified, the dynamics of CCNB1IP1 foci localization 
are observed to coordinately decrease, putatively in accordance with sites of class I 
crossing over. The dynamics of CCNB1IP1 localization from many foci during 
pachytene, to relatively few by late pachytene, is reminiscent to the dynamics of 
meiotic nodule maturation as they select towards and recruit additional factors towards 
stabilization of intermediates and final formation of crossovers. A role for CCNB1IP1 
in maintaining meiotic nodule progression and specification of crossing over would be 
consistent with the failure to form crossovers in the Ccnb1ip1mei4/mei4 animals. 
While it is known that SUMO-conjugates function in DSB repair of somatic 
cells, it has still not been determined what roles SUMOylation might play in meiotic 
DSB repair and crossing over. Localization of a putative SUMO E3 ligase directly to 
SCs and a role in maturation of MNs offers significant implications towards 
understanding this role of meiotic-specific SUMO-conjugates at DSBs of meiocytes.  
 
Interrogation of meiotic progression in Ccnb1ip1mei4/mei4 spermatocytes. 
Prophase I of meiosis represents a complex series of events in which the 
dominant events include the initiation of recombination through double strand break 
formation, chromosome pairing through DNA-directed homology search, chromosome 
condensation and attachment through both DNA interaction and the proteinaceous 
synaptonemal complex, progressive DNA repair, and finally faithful separation of 
homologous chromosomes along the metaphase plate facilitated by resolution of the  
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Figure 4.1. CCNB1IP1 localizes to the Synaptonemal Complex of pachytene 
spermatocytes. 
Immunolocalization of CCNB1IP1 to the Synaptonemal Complex cores of 
spermatocytes during Pachynema. Numerous punctate foci are observed dispersed 
across chromosome cores. CCNB1IP1 localization decreases in mid- to late- 
pachytene to a few residual foci per SC core, presumably marking the sites 
specified as crossovers. (Arrowheads indicate chromosome enlarged for higher 
resolution) 
SYCP3 
SYCP3 
SYCP3 
CCNB1IP1 
CCNB1IP1 
CCNB1IP1 
CCNB1IP1 
CCNB1IP1 
CCNB1IP1 
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 crossover which acts as the final physical tether between homologues. It has 
previously been reported that while meiosis fails in the Ccnb1ip1mei4/mei4 animals, the 
initial events of initiation, pairing, condensation, attachment and SC formation appear 
normal. It is at the final events of homologous chromosome segregation facilitated 
through crossing-over at which failure is observed; MLH1 and MLH3 fail to localize 
in the effected spermatocytes, indicating a failure to fully mature meiotic nodules and 
specify final sites of crossing-over.  
Because I believe CCNB1IP1 to be a SUMO E3 ligase and these results show 
its localization to foci on the SCs, putative sites of crossover intermediates, I was 
initially curious if a defect in CCNB1IP1 would have any grossly observable 
deficiency in SUMO-conjugate localizations during pachytene. In order to understand 
the Ccnb1ip1mei4/mei4 failed progression in intervening events between synapse and 
final formation of sites of crossing-over, immunolocalization was deployed to assess 
the proper localization or dysfunction of known proteins involved in DNA damage 
repair and maturation of meiotic nodules.  
I was interested to understand the localization of the previously reported 
SUMO-modified proteins in spermatocytes [9]. While it is unlikely that CCNB1IP1 
represents the dominant SUMO E3 ligase functioning though meiosis, due to the total 
defect to specify obligate crossing-over it is possible that CCNB1IP1 specifies a major 
contribution of the SUMO proteome during Prophase I. Antibodies specific to 
SUMO1 and SUMO2/3 were used as probes against meiotic chromosome spreads as 
previously described. The gross-localization patterns of SUMO isoforms did not vary 
from WT and mutant spermatocytes (fig 4.2). SUMO1 was seen to localize to the 
heterochromatic regions of the Sex Body and centromeric regions of synapsed 
chromosomes while the localization of SUMO2/3 was likewise observed at the Sex 
Body and centromeric domains. Noting that gross defects in SUMOylation were not  
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Figure 4.2. Gross SUMOylation remains unperturbed in Ccnb1ip1mei4/mei4 
spermatocytes. 
Gross levels of (A) SUMO1 and (B) SUMO2/3 conjugates appear unperturbed in 
pachytene spermatocytes lacking CCNB1IP1. Major localizations of SUMO-
conjugates appear at the heterochromatic regions of the Sex Body and 
pericentromeric regions. Together with the previously observed CCNB1IP1 
localization to foci of similarly staged spermatocytes suggests a directed, rather 
than global, function of CCNB1IP1-mediated conjugation. 
A 
B 
WT Ccnb1ip1mei4/mei4 
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 apparent in the affected spermatocytes, it is reasonable to understand that CCNB1IP1 
likely targets only a subset of the SUMO-modified proteome and may not be apparent 
against the otherwise normally modified proteome. 
Since the role of crossing-over, and recombination more generally, is to repair 
the SPO11 catalyzed DNA damage necessary for the homology search, I moved to see 
if large amounts of DNA damage (as marked by phosphorylated-H2AX; ɣH2AX) 
remained in the mutant spermatocytes. The major defect resultant from 
Ccnb1ip1mei4/mei4 is lack of class I crossovers, and thus it is presumed that the majority 
of DNA damage is repaired through the dominant gene conversion mechanism. In 
agreement with prior knowledge, I did not observe large amounts of global ɣH2AX 
localization. However, pachytene spermatocytes do reveal low level of residual 
ɣH2AX in domains along chromosome cores (fig. 4.3a). The low signal level at 
domains along chromosomes of Ccnb1ip1mei4/mei4 spermatocytes is reflective of failure 
to repair residual DSBs and it agrees with failure to repair DSBs through crossing 
over. The particular defect of CCNB1IP1 localization to meiotic nodules does not 
appear to have an effect on the global process of DNA damage response, but rather 
remains localized to those meiotic nodule sites that would otherwise be destined as 
crossovers. 
The MHS4-5 complex plays an essential role in meiotic nodule maturation. 
Understanding that the defect of Ccnb1ip1mei4/mei4 is presumably finely attenuated to 
the maturation of meiotic nodules into sites of crossing-over, I examined the 
localization dynamics of MSH4 as these nodules mature. In WT meiocytes, MSH4 
foci will mark intermediately maturing nodules which are progressively selected from 
approximately 100 sites to roughly 30-35 meiotic nodules that will be terminally 
marked by MSH4 and later displaced by MLH1/3 at final sites of crossing over. In 
large part, the constituents of these growing meiotic nodules remain unknown, as do  
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Figure 4.3. Repair of Double Strand Breaks is impaired in Ccnb1ip1mei4/mei4 
spermatocytes. 
(A) Low levels of residual ɣH2AX, a mark of unrepaired DSBs, are seen in 
Pachynema Ccnb1ip1
mei4/mei4
 spermatocytes. The low level of residual DSBs 
reflects that the vast majority of crossover-independent DSB repair is unperturbed 
in these spermatocytes defective for crossover-dependent DSB repair. DSBs are 
progressively matured (B; late zygotene/early pachytene) towards sites of repair 
through crossing-over (C; mid/late pachytene) through stabilization of the MSH4-
MSH5 heterodimer. Ccnb1ip1
mei4/mei4
 spermatocytes display retained MSH4 
localization in mid/late pachytene (C), reflective of regulation failure to mature 
meiotic nodules towards chiasmata.  
B 
A 
WT Ccnb1ip1mei4/mei4 
SYCP3 MSH4 
MSH4 MSH4 
MSH4 
SYCP3 SYCP3 
SYCP3 
H2AX H2AX SYCP3 SYCP3 
C 
84 
 the mechanisms that drive their selection, maturation, and processing of crossover 
choice. Using antibodies directed at MSH4, I am able to identify defect in the 
maturation of these meiotic nodules in the nuclei of Ccnb1ip1mei4/mei4 spermatocytes 
(fig. 4.3b,c). By onset of late pachytene MSH4 localization of WT spermatocytes 
matures down to those few foci marking late MNs and soon-to-be displaced by 
MLH1/3 as final crossing over is specified. In the Ccnb1ip1mei4/mei4 spermatocytes, 
many MSH4 foci are retained towards late pachytene. These results indicate failure to 
mature MNs and designate DSB repair towards repair through crossing over. 
 
Observing in vivo expression of CCNB1IP1 using fluorescent tags 
Having established CCNB1IP1 localization to SC cores of Prophase, the 
dynamics of its processing at sites of meiotic nodule maturating, and the dysfunction 
in localization of essential crossing-over intermediaries such as MSH4, MLH1, and 
MLH3 I wished to visualize CCNB1IP1 dynamics in the live animal, in vivo. The 
dynamic localization of CCNB1IP1 during Prophase I at presumed sites of crossover 
fate decisions made me suspect CCNB1IP1 would provide a beautiful in vivo protein 
marker through which to assess faithful progression of Prophase I. Additionally, my 
previous two-hybrid interaction and in vitro studies indicating a role for CCNB1IP1 in 
SUMOylation essential for maturation of MNs drew my interest in providing an 
epitope-tagged transgene through which to identify SUMO-conjugates unknown in the 
MNs. Such an in vivo tool would allow for further precise study in totality of 
CCNB1IP1, SUMO-conjugates, as well as a marker to monitor progression of DNA 
repair though crossing-over in other mutant animals defective for crossing-over. 
Towards developing such a tool for in vivo monitoring CCNB1IP1 dynamics, 
and general marking of formation of meiotic crossing over, a transgenic mouse 
strategy was developed. Using the constructs previously implemented for expression 
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 in the HEK293 and CHO cells of tissue culture, the CMV promoter driving expression 
of CCNB1IP1mCherry was replaced with the previously characterized Tcp10b promoter 
[18] (fig. 4.4). TCP10 is restrictively expressed in developing spermatocytes from the 
onset of Pachynema. The expression driven by the promoter of Tcp10 closely mimics 
that of endogenous CCNB1IP1 and thus offered an ideal driver for the chimeric 
Tcp10-Ccnb1ip1mCherry transgene.  
ESCs were clonally selected (fig 4.4b) and chimeric animals were set to 
breeding. The F1 generation animals would be heterozygous for allele and Tcp10-
Ccnb1ip1mCherry should express the fluorescent tag from the transgene. Unfortunately, 
in all ESC-derived animals, there was failure to detect any level of CCNB1IP1mCherry. 
Families of transgenic animals were also derived from random integration of this 
similarly derived construct though the methods of pronuclear injection of linearized 
DNA (fig 4.4c). These injections yielded two pronuclear-derived transgenic founders 
for Tcp10-Ccnb1ip1mCherry (fig 4.4d). However, as before, progeny from these Tcp10-
Ccnb1ip1mCherry founders failed to express the chimeric protein. 
Development of a fluorescent marker through which to live monitor in vivo 
specification of sites of crossing-over would be a very useful tool. It is a project 
worthy of pursuit, but unfortunately was not successful in this case. Additionally, the 
epitope-tagged chimeric protein of CCNB1IP1mCherry would have offered a clean 
mechanism through which to purify, in vivo, CCNB1IP1 and the proteins through 
which it acts upon in the spermatocyte. Although this transgenic approach to 
monitoring and identifying constituents of the MNs and those proteins involved in 
specification of sites for obligate crossing-over were not pursued further, It should 
continue to be considered for future efforts, as this would provide a valuable 
molecular tool. 
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Figure 4.4. Transgenic animals carrying CCNB1IP1 marked with the 
mCherry fluorescent conjugate.  
(A) ESCs were electroporated with DraIII linearized plasmid of Tcp10-
Ccnb1ip1
mCherry
 under regulation of the pachytene specific promoter from Tcp10 
(arrows indicate approximate location of genotyping primers). (B) Three clonal 
lines of ESCs (B3, A7, A2) were identified as candidates for blastocyst injections. 
(C) The allele used for ESC selection, panel A, was liberated of the neo gene 
through excision of the DraIII-BsaI fragment prior to injection to pronuclear staged 
embryos (allele-specific genotyping primer indicated by arrows). (D) Two founder 
animals derived from pronuclear injections of Tcp10-Ccnb1ip1
mCherry
. 
A 
mCherry Ccnb1ip1 Tcp10p1.3 neo 
DraIII 
B 
100 
200 
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 Discussion 
In these studies, I set forth to understand the localized sites of CCNB1IP1 
function. Previous results had uncovered failure to establish obligate crossing-over, 
pointed towards SC-association, and supported the hypothesis of CCNB1IP1 a meiotic 
co-regulator designating proteins for posttranslational modification by SUMO. As a 
primary concern, I observed CCNB1IP1 associates with the SC cores of pachytene 
spermatocytes. CCNB1IP1 localization dynamics are consistent with those observed 
for the maturation of MNs and the selection of DSB repair towards crossover vs. 
alternate non-crossover fates. The persistent few CCNB1IP1 foci in late pachytene 
spermatocytes suggests a role for CCNB1IP1 in terminal stabilization of crossing-over 
intermediates. That CCNB1IP1 is neither a putative clamp to stabilize nucleic acid 
structures nor a catalytic enzyme implicated in processivity of crossing-over is 
exciting. Rather, CCNB1IP1 presents as a co-regulator acting directly at the sites of 
crossing-over, from which multiple proteins and pathways are synchronized. Thus 
CCNB1IP1 dynamically localized to maturing MNs offers entrance into further 
appreciation of the numerous yet unknown factors involved in stabilization of the 
obligate crossovers and the unappreciated role SUMO-conjugates may play in meiotic 
DSB repair. 
Significantly, I have observed that the dominant SUMO-conjugates in 
spermatocytes remain unperturbed in Ccnb1ip1mei4/mei4 animals. The bulk of the 
SUMO-proteome in spermatocytes localizes to heterochromatic regions of the Sex 
Body and centromeres. These heterochromatic SUMO-conjugates appear unaltered in 
the absence of the CCNB1IP1 SUMO E3 ligase function. This lack of global SUMO 
alterations is in agreement with the presumed function of CCNB1IP1 as a regulator at 
those small fractions of DSBs to be repaired through crossing-over. Such a localized 
and specific effect upon crossing-over is seemingly internally consistent with the lack 
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 in crossing-over, the directed CCNB1IP1 localization putative maturing sites of 
crossing-over, and lack of a global alteration of the SUMO-proteome. Presumably 
with sufficiently strong reagents and detection sensitivity, the fraction of the SUMO-
proteome altered within sites maturing towards crossing-over would be detected in the 
Ccnb1ip1mei4/mei4 spermatocytes. 
The failure to stabilize and mature intermediates towards completion of 
crossover-mediated DSB repair would be expected to result in lingering DNA damage. 
Such damage would be sequestered within residual ɣH2AX domains. Fitting with this 
suspicion, small regions of faintly persistent ɣH2AX are detected in the 
Ccnb1ip1mei4/mei4 spermatocytes. This unrepaired DNA damage is further proof that the 
failing spermatocytes lack direction towards final maturation of crossovers. 
Concurrently to the persistent DNA damage, the failure to form terminally specified 
crossing-over is reflected in persistence of MSH4 localization late pachytene 
spermatocytes. MSH4 dynamic localization is a mark of intermediate processing of 
sites selected towards the few residual repaired though crossing-over. The failure of 
Ccnb1ip1mei4/mei4 effected spermatocytes to clear the majority of MSH4-localized 
intermediates reflects the defect in late stage terminal specifications of crossing-over 
as regulated by CCNB1IP1 localized action. 
Taken together, these results localizing CCNB1IP1 site of function to those 
specific domains selecting towards the obligate crossovers is quite exciting. Fitting to 
the originally observed phenotype presenting singular defect in crossover 
specification, these fine detail molecular phenotyping reveal CCNB1IP1 as a 
poignantly directed regulator at the sites of crossover. CCNB1IP1 localizes to the 
discrete foci presumably marking crossover intermediates, readily observed domains 
of dense SUMO-conjugates are unperturbed by CCNB1IP1 deficiency, and residual 
DNA damage is congruent with failure to further process MSH4 stabilized 
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 intermediates which thusly go unrepaired. Knowing that CCNB1IP1 does not act 
directly to resolve intermediates, but rather presents and a posttranslational regulator 
and point of convergence for coordination of the intricacies involved in crossover 
maturation, offers CCNB1IP1 as an important candidate to monitor and build towards 
understanding the finer details of crossing-over. 
 
Materials and Methods 
Surface spread meiotic nuclei 
Testis from adult or 21 day old mice were dissociated in PBS so to liberate the 
spermatocyte cells from tubules. The washed cellular fraction was suspended 
hypotonic solution (1.125g Sucrose, 25mL water) to suitable density. Cells were 
added drop-wise to poly-lysine coated slides (Fisher Sci. Cat. No. 22-034-979), and 
incubated at room temperature for 1hr. Two drops of 0.05% TritonX-11 were added to 
settled spermatocyte slides, incubated for 10mins at room temperature, followed by 
eight drops of 2% paraformaldehyde/0.02% SDS solution with incubation for an 
additional 1 hour. Fresh slides washed in PBS were then used for immunolocalization 
studies. 
 
Immunolocalization of proteins in meiotic nuclei 
Surface spread nuclei were blocked with 5% donkey serum in PBST (o.1% 
Tween20 in PBS) followed by incubation with primary antibodies at 4 C, overnight. 
Slides were washed three times in PBST, drained and incubated for 1hr with a 1:1000 
dilution of Alexa Fluor conjugated secondary antibodies (Invitrogen). Washed slides 
were mounted and DAPI stained with ProLong Gold Antifade (Invitrogen, Cat. No. 
P36935). Primary antibodies were; anti-HEI10/CCNB1IP1 (abcam, Cat. No. 
ab118999), anti-SYCP3 (abcam, Cat. No. ab97672 or Cat. No. ab15093), anti-MSH4 
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 (abcam, Cat. No. ab58666), anti-SUMO1 (Cell Signal, Cat. No. 4931), anti-SUMO2/3 
(Cell Signal, Cat. No. 4971), anti-ɣH2AX (Upstate, Cat. No. 07-164). 
 
Generation of the TCP10-driven Ccnb1ip1mCherry transgene 
The Ccnb1ip1mCherry transgene under promoter control of the Tcp10b gene was 
derived from the previously described pCcnb1ip1mcherry. The CMV promoter from 
pCcnb1ip1mcherry was excised at the AseI and NheI sites and replaced by the 1.3kb 
promoter fragment from pTcp1.3-Lac-SV, generating the pTcp10-Ccnb1ip1mCherry 
expression vector. 
 
Selection and screening of ESCs for transgene 
Linearized pTcp10-Ccnb1ip1mCherry was electroporated to ESCs and selected 
for integration through neomycin resistance. Clones were screened for integration with 
primers spanning the 3’ terminus of pTcp10-Ccnb1ip1mCherry (forward primer within 
mCherry: CACCATCGTGGAACAGTACG; reverse primer in vector backbone: 
TCAGGTTCAGGGGGAGGT). ESCs integrating the 5’ neo and full Tcp10-
Ccnb1ip1mCherry transgene would amplify the 3’ PCR product of 155bp. 
 
Transgenic animals through pronuclear injection  
The Tcp10-Ccnb1ip1mCherry transgene for pronuclear injection was produced 
from pTcp10-Ccnb1ip1mCherry linearized by digestion at the DraIII and BsaI sites, 
excising out the neo-resistance cassette. This linearized DNA was injected into 
pronuclear staged embryos and founder animals were genotyped across the allele 
specific Ccnb1ip1-mCherry junction (forward primer within Ccnb1ip1: 
GGAAATCAAGGTGGTGGAGA; reverse primer within mCherry: 
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 AAGCGCATGAACTCCTTGAT). The allele specific PCR predicts a 252bp product 
from animals carrying the Tcp10-Ccnb1ip1mCherry transgene. 
 
Western blot analysis 
 Protein concentrations were assessed with BCA kit (Pierce) as per 
manufacturer instructions. 30µg protein for cell lysates, or total protein quantity from 
immunoprecipitations and in vitro SUMOylation reactions, was separated through 
SDS-PAGE and electro-transferred to PVDF membrane, and probed with designate 
antibodies per standard protocols. Detection of HRP-conjugated secondary antibody 
through chemiluminescence (Pierce ECL and EMD Millipore Luminata Forte). 
Antibodies used: anti-DsRed (Clontech: 632496), anti-CCNB1IP1 (GenScript: 
custom).
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CHAPTER 5 
 
Summary of findings  
 
In this thesis I have set forth to further our understanding of the defect causal 
to the infertility of the mei4 animals isolated in a forward genetic screen aimed at 
uncovering and understanding the genetics governing mammalian meiosis. The 
original identification of mei4 discovered a lack to specify obligate crossovers, 
resulting in meiotic arrest of otherwise phenotypically normal animals. The genetic 
defect in mei4 was mapped to Ccnb1ip1, a gene with unknown functions within the 
gonads of both sexes. It was my goal to understand the function of CCNB1IP1, and 
how the defect in Ccnb1ip1mei4/mei4 animals leads to meiotic arrest. 
In agreement with the meiotic specific phenotype, and defect in the 
pachytene/diplotene transition to form sites of crossing-over, Western blot mediated 
expression analysis of the mouse testis found CCNB1IP1 restricted to the gonad, and 
detectable as the first wave of spermatogenesis enters pachynema when crossover 
intermediates are progressively stabilized and matured towards the obligate crossover. 
While the Cccnb1ip1mei4/mei4 animals are infertile, they do produce some low level of a 
truncated CCNB1IP1mei4. These characterizations agree with Ccnb1ip1 as essential to 
meiosis and the locus of the causal mei4 mutation. 
Although the mei4 animals were otherwise normal in all tissues other than the 
testis, my original work toward discovering informative protein-protein interactions 
with CCNB1IP1/HEI10 was predicated on previous studies of CCNB1IP1/HEI10 
function in somatic cells; CCNB1IP1 had been implicated as an ubiquitin E3 ligase 
regulating cell cycle through directed degradation of cyclin B. Informed by those 
previous studies, I replicated the two-hybrid screen while using a more complete 
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 fragment of the mouse CCNB1IP1 in conjunction with a two-hybrid “prey” library 
from the adult testis, to discover those protein-protein interactions reflective the tissue 
expression analysis and phenotyping had restricted CCNB1IP1 within. Through two-
hybrid discovery of protein-protein interactions between CCCNB1IP1 and SUMO2 as 
well as predicted targets of SUMO-conjugation, I developed the hypothesis that 
CCNB1IP1 functions as a SUMO E3 ligase in regulating the posttranslational 
modifications of proteins more directly involved in the maturations of crossover sites. 
Having implicated CCNB1IP1 as a SUMO E3 ligase based upon both 
conservation of domain and protein-protein interactions, I next moved to validate this 
SUMO ligase activity through direct biochemical evaluation. In vivo studies of 
CCNB1IP1 were obstructed due to lack of spermatocyte cell culture techniques and 
aggregations of CCNB1IP1 resembling polycomplex structures when expressed in 
cultured somatic cells. Fortunately, the SUMOylation of peptides can be recapitulated 
in vitro with recombinant proteins. Through this recapitulated SUMOylation reaction, 
soluble recombinant CCNB1IP1 was observed to be autoSUMOylated, a property 
previously identified for E3 ligases when terminal targets for SUMO-conjugation are 
lacking. Reagents limited my ability to detect CCNB1IP1-dependent SUMOylation of 
target proteins through these similar in vitro recapitulations, but efforts towards 
building a synthetic SUMO E3 ligase with inducible associations to suspected targets 
of SUMOylation show GGN and 4930455F23RIK as targets of posttranslational 
modification when induced to interact with this synthetic SUMO E3 ligase. 
CCNB1IP1 thus displays biochemical autoSUMOylation consistent with a SUMO E3 
ligase, and proteins to which it interacts are themselves posttranslationally modified 
dependent upon interaction with a putative SUMO E3 ligase. 
Having supported my hypothesis that CCNB1IP1 functions as a SUMO E3 
ligase essential to meiotic crossing-over regulation, I moved to understand the fine 
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 detail sites of action for CCNB1IP1 and the defect in the Ccnb1ip1mei4/mei4 animals. 
Immunolocalization of CCNB1IP1 confirms previous suspicion as a SC-associated 
protein acting upon those sites progressing towards crossing-over. The points of 
CCNB1IP1 localization along SC cores decrease in number as meiocytes approach 
diplonema, the point at which crossovers are terminally matured. These CCNB1IP1 
dynamics, together with low levels of persistent DNA damage and failure to displace 
MSH4 through maturation of crossover intermediates, implicate CCNB1IP1 as 
functioning in regulating the processing of crossover intermediates during pachynema. 
It is thus hypothesized that CCNB1IP1 functions at maturing crossover intermediates 
to impart SUMO modifications upon other proteins and alter their activity, 
localizations, and/or facilitating the building of more protein-dense MNs at the sites of 
those intermediates designated to resolve as the Class I crossovers marked by the 
MLH1/3 heterodimer (fig 5.1). 
Taken together, the results of this thesis reveal CCNB1IP1 and a meiotic co-
regulator specifying proteins for posttranslational regulation through SUMOylation. 
CCNB1IP1’s SUMO-dependent regulation of crossing-over is finely localized to 
crossover intermediates and failure in this SUMO-dependent regulation results in 
failure to repair DSBs though the obligate crossover. 
In the broader sense, these studies with CCNB1IP1 begin to reveal the 
conserved role SUMO-conjugation plays in the regulations of DNA damage repair (a 
general principle), and meiotic recombination (uncovered here). While the study of 
SUMO is a relatively new field, it has become clear from work in somatic cells that 
SUMO regulated functions are diverse but as discussed earlier, SUMO may be 
particularly important in DNA damage response and repair regulation. Uncovering a 
role for SUMO-dependent regulation in the maturation of crossover intermediates is   
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Pachynema Zygonema Diplonema Leptonema 
SYCP3 SYCP1 CCNB1IP1 MLH1/3 
RAD51 MSH4/5 Unidentified proteins 
Figure 5.1. Model of localized CCNB1IP1 regulations stabilizing maturing 
crossover intermediates. 
CCNB1IP1 functions locally at the sites of crossover intermediates during 
Pachynema of prophase I meiocytes. As meiotic DSB repair progresses towards 
those sites of Class I crossover-mediated repair, CCNB1IP1 localizations begin at 
early Pachynema and dynamically decrease towards those final crossover as 
marked by the MLH1/3 heterodimer. CCNB1IP1 imparts SUMO modifications 
upon some number of unidentified proteins at crossover intermediates and alters 
their activity, localizations, and/or facilitates the building of more protein-dense 
MNs at these intermediates designated to resolve as the Class I crossovers. 
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 further evidence of the conserved role SUMO plays in regulations of DNA damage 
response.  
Within the field of meiosis, the processes through which crossovers are 
regulated remains poorly understood, and the wide roles of SUMOylation within any 
function of meiosis is largely unknown. It is exciting that CCNB1IP1 implicates 
SUMO-mediated regulations in the maturation of crossover intermediates. 
 
Future thoughts 
CCNB1IP1 presents itself as the entry point to identifying SUMO-conjugates 
and their more direct roles in crossing-over. Because CCNB1IP1 finely localizes to 
sites of crossover intermediates, and because CCNB1IP1 directly interacts with 
proteins regulated through conjugation by SUMO, a primary interest should be the 
immunoprecipitation of CCNB1IP1 and the identification of those in vivo interacting 
partners modified by SUMO at these particular crossover intermediates. This type of 
proteomic discovery of SUMO-conjugates is complicated by the branch-structure 
peptides produced from digestion of SUMO-conjugates.  
Mass spectrometry relies on computational identification of proteins in mixture 
based upon peptide sizes retrieved from digestions and matching these retrieved 
masses to those predicted from in silico digestions. While accommodating for the 
minor mass increases resultant from small mass changes of phosphorylation and 
acetylation is relatively easy, the branched fragment from SUMO complicates the 
analysis of digestion fragments and thus the discovery of unknown constituents in the 
protein isolates. The technical difficulties of this in silico analysis of SUMO-
conjugates is made nearly insurmountable from anything less than an exceptionally 
clean and “simple” mixture of peptides. Thus, identifying the CCNB1IP1-interacting 
proteins from meiocytes would be primarily reliant upon efficient co-
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 immunoprecipitations. Traditionally, immunoprecipitations towards discovering 
SUMO-conjugates are best produced through cells in culture, followed by tandem 
affinity purifications under strong denaturing conditions so as to remove most 
contaminants and produce an exceptionally clean mixture. Due to the goal of 
identifying CCNB1IP1 interacting partners and SUMO-conjugates from meiocytes, 
the protocols of purification traditionally used for SUMO-conjugates are precluded in 
this experiment. The in vivo immunoprecipitation of CCNB1IP1 and its interactors 
would thus be best produced through highly selective epitope-tagging of CCNB1IP1 
in the animal. Because prior attempts at such a transgene were unsuccessful, I would 
approach this through targeting the endogenous locus. And because another interest 
would be the in vivo live imaging of CCNB1IP1 and more generally the dynamics of 
intermediate MNs, I would maintain the mCherry fluorescent-tag fusion as both a 
means for live imaging and efficient immunoprecipitations. Additionally, since the 
traditional use of denaturing immunoprecipitations is ill-advised in this in vivo 
discovery of CCNB1IP1-interacting proteins, it would further be necessary to 
“simplify” the proteins for identification through size fractionations across 
polyacrylamide gel prior to digestion for mass spectrometry. Once a clean (i.e efficient 
immunoprecipitation) and simple (i.e. size fractioned) mixtures of CCNB1IP1-
interacting proteins are isolated, the experiment is approachable and in silico tools 
such as ChopNSpice would identify these SUMO-conjugates at the sites of 
intermediate MNs. An additional advantage of this in vivo identification of 
CCNB1IP1-interacting proteins is that I believe the SUMO E2 ligase, UBE2I/UBC9, 
would be identified through Western blot or protein sequencing of the mCherry-
mediated co-immunoprecipitation. This in vivo interaction between CCNB1IP1 and 
UBE2I has been difficult because of limitations largely due to the available anti-
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 CCNB1IP1 antibody and having the mCherry epitope would present an especially nice 
solution to this technical difficulty. 
An additional consideration to this CCNB1IP1-mediated discovery of SUMO-
conjugates may be that the steps and conditions used to yield appropriately clean and 
simplified mixtures, together with the apparent specificity of CCNB1IP1 at those few 
MN sites may result in samples below the detection thresholds of accurate mass 
spectrometry analysis, especially considering the complicated computations therein for 
SUMO-conjugates.  This complication can be overcome through isolating a starting 
sample of pachytene spermatocytes enriched from adult testis by either velocity 
sedimentation separation with STA-PUT or cell sorting based upon DNA content and 
size via flow cytometry. 
I believe the identification of SUMO-conjugates has the most interesting long-
term implications resultant from these CCNB1IP1 studies. Through CCNB1IP1, and 
recently RNF212, we are appreciating the role SUMO plays in meiosis I. While 
discovery of CCNB1IP1-interacting partners is a direct approach to offer in vivo 
confirmation of the studies in this thesis, a more global identification of SUMO-
conjugates in meiocytes may be both more significant and a more quantifiably 
accurate method to assess CCNB1IP1-depent SUMOylation and defects in the 
Ccnb1ip1mei4/mei4 animals. As a general tool for studies of SUMO in the mouse, 
transgenic mice expressing a tagged-SUMO regulated from the endogenous locus 
would prove a valuable resource. Traditionally a direct purification of SUMO and thus 
the SUMO-conjugates through tandem affinity purification (TAP) has been the most 
successful methodology for unbiased discovery of SUMO-conjugates. For the specific 
purpose of understanding the role of SUMO-mediated regulations in meiosis, 
generation of mice expressing TAP-tagged SUMO1/2/3 alleles would allow for 
efficient purification of SUMO-conjugates from spermatocytes. Having the 
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 foundational knowledge of proteins SUMOylated during meiosis, and the dynamics of 
the SUMO proteome within each stage of Prophase I, might prove as informative and 
important towards future studies as our understanding the transcriptome has been. 
Furthermore, comparing the dynamic SUMO proteome between SUMO1, SUMO2 
and SUMO3 would help understand if SUMO proteins are complementary or to what 
extant their targets, and possibly functions, differ. The reference database of SUMO in 
meiosis, and the resources of TAP-tagged SUMO in the mouse would have significant 
impacts toward advancing the understanding of SUMO-mediated regulation in higher 
order animals. 
The advantage of knowing the SUMO proteome would also serve to more 
accurately validate and further the CCNB1IP1 studies I have presented in this thesis. 
As I have already elaborated, discovery of SUMO-conjugates through interactions 
with CCNB1IP1 is technically very challenging. However, if the ground state of the 
SUMO-proteome is prior knowledge, then the identification/confirmation of those 
SUMO-conjugates co-immunoprecipitated with CCNB1IP1 is much more reliable. 
Because the library of branched peptides to identify would then be a priori knowledge 
in the CCNB1IP1 immunoprecipitation samples, the proteins submitted to mass 
spectrometric analysis do not need be as clean nor as “simple” as previously 
described. Furthermore, having the knowledge of the SUMO1 vs. SUMO2 vs SUMO3 
proteome would allow for more justified conclusion of the SUMO isoform modified to 
the CCNB1IP1 interactors, in vivo. Having knowledge of those few proteins directly 
interacting with CCNB1IP1, the SUMO isoform regulating these proteins, and the 
TAP-tagged transgenic animal for that SUMO isoform would thus present the very 
nice option to quantify the differential SUMOylation levels of those a priori targets of 
SUMOylation in the WT vs Ccnb1ip1wt/mei4 vs Ccnb1ip1mei4/mei4 pachytene 
spermatocytes. Indeed, this objective to comparatively quantify differential 
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 SUMOylation between effected animals is not reliant upon prior co-
immunoprecipitation with an epitope-tagged CCNB1IP1, but the additional 
CCNB1IP1 immunoprecipitation step would serve to reduce the complexity of data 
analysis. Reducing the complexity is advantageous because it would narrow to a 
specific SUMO isoform and focus upon those SUMO-conjugates directly influenced 
by CCNB1IP1 interaction, but indeed the SUMO proteome in its entirety could be 
differentially assessed between the Ccnb1ip1 alleles.   
Although the above mentioned proteomic studies would identify the 
CCNB1IP1 interactome as a whole, the directed studies of candidate CCNB1IP1 
interacting partners may prove more traditionally straightforward. Because of 
CCNB1IP1’s focal localizations to intermediate MNs, narrowly focused interaction 
studies of similarly localized candidate proteins could prove informative. In this 
approach, biased by candidates known to localize to MNs, antibodies suitable for 
immunoprecipitations are the limiting reagents and in most circumstances the directed 
yeast two-hybrid assessment for interaction would be the most approachable option. 
As discussed earlier, the MSH4/5 heterodimer stabilizes intermediate MNs and the 
MLH1/3 heterodimer marks sites of crossing-over. Because the Ccnb1ip1mei4/mei4 
animals display retained MSH4 localization, and fail to localize MSH1/3, it is 
reasonable to directly assess potential protein-complex interactions of CCNB1IP1 with 
MSH4, MSH5, MLH1, and MLH3. Additionally, an interaction with RNF212/Zip3 
should be considered- RNF212 localizes to intermediate MNs as well, and in the 
Cccnb1ip1mei4/mei4 animals it has been shown that RNF212 foci at intermediate MNs 
persist and fail to mature similar to the MSH4 dynamics reported here (Neil Hunter, 
unpublished). Similar to CCNB1IP1, RNF212 is hypothesized to function as a SUMO 
E3 ligase and contains an internal coiled-coil domain which may mediate an 
interaction with CCNB1IP1. It should be noticed that these proteins were not isolated 
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 from my previously reported two-hybrid screen, but this may be a function of simply 
not recovering that interaction, lack of suitable representation of these clones in the 
library screened, or the necessity of a full-length clone of these partners for the tertiary 
structure adequate to a CCNB1IP1 interaction.  
From the studies I have presented in this thesis, two candidate genes for further 
explorations on putative roles in meiosis jump out: Ggn and 4930455f23Rik/Ccdc181. 
Ggn has recently been knocked out in the mouse and found essential to 
embryogenesis. However, the studies with Ggn haploinsufficient mice find that GGN 
is involved in meiotic DSB repair and those mice with half the GGN levels retain 
some moderately increased localizations of RAD51 into pachytene. This single report 
on the role of Ggn function in meiosis is incomplete and lacked refined staging of 
pachytene spermatocytes and thus calls into question the significance of the 
“moderate” retained/delayed dynamics of RAD51 localizations and the reported DSB 
repair defect. Nevertheless, my studies here implicate a role for GGN in meiosis, 
supported by its specific expression during spermatocyte entry into Pachynema and 
the previously discussed interaction cascade between CCNB1IP1, GGN, GGNBP1, 
and MEI1 (the latter of which is essential to DSB initiation of meiosis). To explore in 
careful detail the role of GGN in meiotic DSB repair is especially attractive due to the 
recent availability of these animals and the evidence for direct interactions linking the 
initiation of meiosis through to maturing Class I crossovers specified by CCNB1IP1. 
Finally, it makes sense to consider 4930455f23Rik/Ccdc181 as a candidate for 
mutation in the mouse. While CCDC181 is expressed in several tissues, it is relatively 
strongly expressed in the testis but does not appear to be expressed in the ovary. 
Ccdc181 maybe represent that minor class of genes with sexually dimorphic functions 
in meiotic prophase I- especially interesting if indeed shown to have a role in 
recombination of in male, but not the female meiocyte. In the testis, CCDC181 
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 expression increases dramatically during 14-18dpp and this expression is consistent 
with a putative role during prophase I. Furthermore, CCDC181, like CCNB1IP1 and 
RNF212 as well as other SC-associated proteins, contains an internal coiled-coil 
domain and may indeed be found to localize to the SC like these other coiled-coil 
domain containing proteins. Although the mutant animals for Ccdc181 are not 
available, mutating the gene would be attractive for its putative role and suspected 
localization at meiotic recombination sites. CCDC181 and GGN together represent 
options of further investigations opened up by identification of CCNB1IP1 as a 
meiotic co-regulator of crossing over. Through the identification of candidate genes 
Ggn and Ccdc181, we appreciate CCNB1IP1’s role in interacting with many other 
proteins towards imparting regulatory marks effecting the diverse functions of these 
yet unappreciated factors in mammalian meiosis. Studies of CCNB1IP1 has presented 
these candidate genes and their corresponding posttranslational modifications for 
further studies. 
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